name,category,termsA kinase (PRKA) anchor protein 14,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm]
A kinase (PRKA) anchor protein 14,UP_SEQ_FEATURE[850002963$chain:A-kinase anchor protein 14, 850106259$mutagenesis site, 850114538$region of interest:RII-binding, 850118574$splice variant]
AT-hook transcription factor,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
AT-hook transcription factor,UP_SEQ_FEATURE[850006381$chain:AT-hook-containing transcription factor, 850102884$DNA-binding region:A.T hook, 850106258$modified residue, 850113997$region of interest:PEST, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ATPase, Ca++ transporting, type 2C, member 1,INTERPRO[450000595$IPR000695:ATPase, P-type, H+ transporting proton pump, 450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005835$IPR006413:ATPase, P-type, calcium-transporting, PMR1-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, type 2C, member 1,OMIM_DISEASE[520000549$benign chronic pemphigus (Hailey-Hailey disease), 520002207$Hailey-Hailey disease]
ATPase, Ca++ transporting, type 2C, member 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, type 2C, member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000356$complete proteome, 790000446$disease mutation, 790000624$golgi apparatus, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, type 2C, member 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850009067$chain:Calcium-transporting ATPase type 2C member 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850106107$metal ion-binding site:Magnesium, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
CCAAT/enhancer binding protein (C/EBP), beta,BIOCARTA[30000160$h_il6Pathway:IL 6 signaling pathway]
CCAAT/enhancer binding protein (C/EBP), beta,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010528$IPR011700:Basic leucine zipper, 450014789$IPR016468:CCAAT/enhancer-binding]
CCAAT/enhancer binding protein (C/EBP), beta,PIR_SUPERFAMILY[630005805$PIRSF005879:CCAAT/enhancer-binding, 630005806$PIRSF005879:CCAAT/enhancer-binding protein]
CCAAT/enhancer binding protein (C/EBP), beta,SMART[760000306$SM00338:BRLZ]
CCAAT/enhancer binding protein (C/EBP), beta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000356$complete proteome, 790000434$differentiation, 790000449$DNA binding, 790000466$dna-binding, 790000811$isopeptide bond, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation, 790001592$ubl conjugation]
CCAAT/enhancer binding protein (C/EBP), beta,UP_SEQ_FEATURE[850010080$chain:CCAAT/enhancer-binding protein beta, 850102580$compositionally biased region:Poly-Pro, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850105852$helix, 850106258$modified residue, 850114423$region of interest:Required for Lys-174 sumoylation, 850117294$sequence conflict, 850117295$sequence variant, 850118624$turn]
CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae),INTERPRO[450016879$IPR018607:Chromosome transmission fidelity protein 8]
CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000258$cell cycle, 790000356$complete proteome, 790000460$dna replication, 790000466$dna-binding, 790001065$nucleus]
CTF8, chromosome transmission fidelity factor 8 homolog (S. cerevisiae),UP_SEQ_FEATURE[850011422$chain:Chromosome transmission fidelity protein 8 homolog]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450003602$IPR004087:K Homology, 450003603$IPR004088:K Homology, type 1, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding, 450016411$IPR018111:K Homology, type 1, subgroup]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43,PIR_SUPERFAMILY[630001466$PIRSF001321:ATP-dependent RNA helicase]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43,SMART[760000291$SM00322:KH, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43,UP_SEQ_FEATURE[850041111$chain:Probable ATP-dependent RNA helicase DDX43, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850104520$domain:KH, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
E1A binding protein p300,BIOCARTA[30000046$h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor, 30000047$h_carm1Pathway:Transcription Regulation by Methyltransferase of CARM1, 30000121$h_g2Pathway:Cell Cycle: G2/M Checkpoint, 30000136$h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology, 30000138$h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System, 30000161$h_il7Pathway:IL-7 Signal Transduction, 30000183$h_mef2dPathway:Role of MEF2D in T-cell Apoptosis, 30000184$h_melanocytepathway:Melanocyte Development and Pigmentation Pathway, 30000210$h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae, 30000216$h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system, 30000224$h_pelp1Pathway:Pelp1 Modulation of Estrogen Receptor Activity, 30000227$h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2, 30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha), 30000236$h_ppargPathway:Role of PPAR-gamma Coactivators in Obesity and Thermogenesis, 30000259$h_RELAPathway:Acetylation and Deacetylation of RelA in The Nucleus, 30000293$h_tgfbPathway:TGF beta signaling pathway, 30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
E1A binding protein p300,INTERPRO[450000168$IPR000197:Zinc finger, TAZ-type, 450000371$IPR000433:Zinc finger, ZZ-type, 450001324$IPR001487:Bromodomain, 450002725$IPR003101:Coactivator CBP, KIX, 450008365$IPR009255:Transcriptional coactivation, 450009371$IPR010303:Protein of unknown function DUF902, CREBbp, 450013195$IPR014744:Nuclear receptor coactivator, CREB-bp-like, interlocking, 450016644$IPR018359:Bromodomain, conserved site]
E1A binding protein p300,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038846$hsa04310:Wnt signaling pathway, 470038848$hsa04330:Notch signaling pathway, 470038850$hsa04350:TGF-beta signaling pathway, 470038856$hsa04520:Adherens junction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038885$hsa04916:Melanogenesis, 470038894$hsa05016:Huntington's disease, 470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma, 470038905$hsa05215:Prostate cancer]
E1A binding protein p300,OMIM_DISEASE[520001093$Colorectal cancer, 520004363$Rubinstein-Taybi syndrome]
E1A binding protein p300,PIR_SUPERFAMILY[630027768$PIRSF036333:transcription coactivator CREB-binding protein]
E1A binding protein p300,SMART[760000262$SM00291:ZnF_ZZ, 760000267$SM00297:BROMO, 760000491$SM00551:ZnF_TAZ]
E1A binding protein p300,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000206$bromodomain, 790000258$cell cycle, 790000316$chromosomal rearrangement, 790000326$citrullination, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000733$host-virus interaction, 790000937$metal-binding, 790000953$methylation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001592$ubl conjugation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
E1A binding protein p300,UP_SEQ_FEATURE[850023871$chain:Histone acetyltransferase p300, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850103166$domain:Bromo, 850104544$domain:KIX, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111035$region of interest:Binding region for E1A adenovirus, 850112430$region of interest:Interaction with HTLV-1 Tax, 850112592$region of interest:Interaction with NCOA2, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850117911$site:Breakpoint for translocation to form MYST3-EP300 and EP300-MYST3, 850118319$site:Interaction with NCOA2, 850118575$strand, 850118624$turn, 850118931$zinc finger region:TAZ-type 1, 850118932$zinc finger region:TAZ-type 2, 850118951$zinc finger region:ZZ-type]
EGF-containing fibulin-like extracellular matrix protein 2,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
EGF-containing fibulin-like extracellular matrix protein 2,OMIM_DISEASE[520001290$Cutis laxa, autosomal recessive, type I]
EGF-containing fibulin-like extracellular matrix protein 2,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
EGF-containing fibulin-like extracellular matrix protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
EGF-containing fibulin-like extracellular matrix protein 2,UP_SEQ_FEATURE[850016990$chain:EGF-containing fibulin-like extracellular matrix protein 2, 850102883$disulfide bond, 850103619$domain:EGF-like 1; atypical, 850103644$domain:EGF-like 2; calcium-binding, 850103667$domain:EGF-like 3; calcium-binding, 850103687$domain:EGF-like 4; calcium-binding, 850103693$domain:EGF-like 5; calcium-binding, 850103696$domain:EGF-like 6; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
EPH receptor A10,INTERPRO[450000618$IPR000719:Protein kinase, core, 450000955$IPR001090:Ephrin receptor, ligand binding, 450001096$IPR001245:Tyrosine protein kinase, 450001270$IPR001426:Receptor tyrosine kinase, class V, conserved site, 450001470$IPR001660:Sterile alpha motif SAM, 450003484$IPR003961:Fibronectin, type III, 450007559$IPR008266:Tyrosine protein kinase, active site, 450008173$IPR008957:Fibronectin, type III-like fold, 450011699$IPR013032:EGF-like region, conserved site, 450012380$IPR013761:Sterile alpha motif-type, 450014581$IPR016257:Tyrosine-protein kinase, ephrin receptor, 450015769$IPR017441:Protein kinase, ATP binding site]
EPH receptor A10,PIR_SUPERFAMILY[630000779$PIRSF000666:tyrosine-protein kinase, ephrin receptor type, 630000780$PIRSF000666:TyrPK_ephrin_receptor]
EPH receptor A10,SMART[760000051$SM00060:FN3, 760000192$SM00219:TyrKc, 760000399$SM00454:SAM, 760000544$SM00615:EPH_lbd]
EPH receptor A10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001586$tyrosine-protein kinase]
EPH receptor A10,UP_SEQ_FEATURE[850017609$chain:Ephrin type-A receptor 10, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850105086$domain:Protein kinase, 850105249$domain:SAM, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ER degradation enhancer, mannosidase alpha-like 2,INTERPRO[450001227$IPR001382:Glycoside hydrolase, family 47]
ER degradation enhancer, mannosidase alpha-like 2,PIR_SUPERFAMILY[630014256$PIRSF017531:mannosyl-oligosaccharide 1,2-alpha-mannosidase, 1A type]
ER degradation enhancer, mannosidase alpha-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001595$unfolded protein response]
ER degradation enhancer, mannosidase alpha-like 2,UP_SEQ_FEATURE[850017746$chain:ER degradation-enhancing alpha- mannosidase-like 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
Enah/Vasp-like,INTERPRO[450000597$IPR000697:EVH1, 450010818$IPR011993:Pleckstrin homology-type, 450013334$IPR014885:VASP tetramerisation, 450015678$IPR017354:Vasodilator-stimulated phosphoprotein]
Enah/Vasp-like,PIR_SUPERFAMILY[630029587$PIRSF038010:vasodilator-stimulated phosphoprotein, 630029588$PIRSF038010:Vasodilator_Phospo]
Enah/Vasp-like,SMART[760000406$SM00461:WH1]
Enah/Vasp-like,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism, 790001399$sh3-binding]
Enah/Vasp-like,UP_SEQ_FEATURE[850017192$chain:Ena/VASP-like protein, 850102586$compositionally biased region:Pro-rich, 850105697$domain:WH1, 850106258$modified residue, 850111645$region of interest:EVH2, 850111646$region of interest:EVH2 block A, 850111647$region of interest:EVH2 block B, 850111648$region of interest:EVH2 block C, 850117294$sequence conflict, 850117295$sequence variant, 850117535$short sequence motif:KLKR, 850118574$splice variant]
Fc receptor-like 4,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc receptor-like 4,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
Fc receptor-like 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000763$immune response, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
Fc receptor-like 4,UP_SEQ_FEATURE[850019116$chain:Fc receptor-like protein 4, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117814$signal peptide, 850117848$site:Breakpoint for insertion to form FCRL4- IGHA1 fusion protein, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor kinase 5,INTERPRO[450000207$IPR000239:GPCR kinase, 450000294$IPR000342:Regulator of G protein signalling, 450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
G protein-coupled receptor kinase 5,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway, 470038841$hsa04144:Endocytosis]
G protein-coupled receptor kinase 5,SMART[760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc, 760000285$SM00315:RGS]
G protein-coupled receptor kinase 5,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
G protein-coupled receptor kinase 5,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850020254$chain:G protein-coupled receptor kinase 5, 850103028$domain:AGC-kinase C-terminal, 850105086$domain:Protein kinase, 850105178$domain:RGS, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850113517$region of interest:N-terminal, 850117295$sequence variant]
GTF2I repeat domain containing 2B,INTERPRO[450003720$IPR004212:GTF2I-like repeat, 450014303$IPR015880:Zinc finger, C2H2-like]
GTF2I repeat domain containing 2B,SMART[760000323$SM00355:ZnF_C2H2]
GTF2I repeat domain containing 2B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
GTF2I repeat domain containing 2B,UP_SEQ_FEATURE[850021046$chain:General transcription factor II-I repeat domain-containing protein 2B, 850105852$helix, 850116107$repeat:GTF2I-like 1, 850116108$repeat:GTF2I-like 2, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
HEG homolog 1 (zebrafish),INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450005635$IPR006209:EGF, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
HEG homolog 1 (zebrafish),SMART[760000153$SM00179:EGF_CA]
HEG homolog 1 (zebrafish),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
HEG homolog 1 (zebrafish),UP_SEQ_FEATURE[850046381$chain:Protein HEG homolog 1, 850102597$compositionally biased region:Ser-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
KIAA1543,INTERPRO[450013247$IPR014797:Protein of unknown function DUF1781]
KIAA1543,SP_PIR_KEYWORDS[790000356$complete proteome, 790000960$microtubule, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA1543,UP_SEQ_FEATURE[850009156$chain:Calmodulin-regulated spectrin-associated protein 3, 850102586$compositionally biased region:Pro-rich, 850103368$domain:CKK, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
NAD kinase,INTERPRO[450002223$IPR002504:ATP-NAD/AcoX kinase, 450015765$IPR017437:ATP-NAD kinase, PpnK-type, all-beta, 450015766$IPR017438:ATP-NAD kinase, PpnK-type, alpha/beta]
NAD kinase,KEGG_PATHWAY[470038796$hsa00760:Nicotinate and nicotinamide metabolism]
NAD kinase,PIR_SUPERFAMILY[630004861$PIRSF004914:ATP-NAD(H) kinase, 630030337$PIRSF500062:ATP-NAD(H) kinase, eukaryotic type]
NAD kinase,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000937$metal-binding, 790001006$nad, 790001008$nadp, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase]
NAD kinase,UP_SEQ_FEATURE[850033402$chain:NAD kinase, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
NDRG family member 4,INTERPRO[450003654$IPR004142:Ndr]
NDRG family member 4,PIR_SUPERFAMILY[630019009$PIRSF023830:Caenorhabditis elegans hypothetical protein ZK1073.1]
NDRG family member 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001162$phosphoprotein]
NDRG family member 4,UP_SEQ_FEATURE[850047002$chain:Protein NDRG4, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850118574$splice variant]
RUN and SH3 domain containing 2,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450003532$IPR004012:RUN, 450010373$IPR011511:Variant SH3]
RUN and SH3 domain containing 2,SMART[760000295$SM00326:SH3, 760000527$SM00593:RUN]
RUN and SH3 domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
RUN and SH3 domain containing 2,UP_SEQ_FEATURE[850026732$chain:Iporin, 850102572$compositionally biased region:Poly-Glu, 850105223$domain:RUN, 850105350$domain:SH3, 850106258$modified residue, 850117295$sequence variant]
Ras and Rab interactor-like,INTERPRO[450002747$IPR003123:Vacuolar sorting protein 9]
Ras and Rab interactor-like,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790001212$polymorphism]
Ras and Rab interactor-like,UP_SEQ_FEATURE[850056672$chain:Ras and Rab interactor-like protein, 850105626$domain:VPS9, 850117295$sequence variant]
Rho family GTPase 1,INTERPRO[450001599$IPR001806:Ras GTPase, 450003145$IPR003578:Ras small GTPase, Rho type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
Rho family GTPase 1,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
Rho family GTPase 1,PIR_SUPERFAMILY[630028684$PIRSF037169:small GTPase, Rho type]
Rho family GTPase 1,SMART[760000148$SM00174:RHO]
Rho family GTPase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001212$polymorphism, 790001236$prenylation]
Rho family GTPase 1,UP_SEQ_FEATURE[850057596$chain:Rho-related GTP-binding protein Rho6, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850117441$short sequence motif:Effector region, 850118575$strand, 850118624$turn]
SH2B adaptor protein 1,INTERPRO[450000852$IPR000980:SH2 motif, 450001635$IPR001849:Pleckstrin homology, 450013461$IPR015012:Phenylalanine zipper]
SH2B adaptor protein 1,KEGG_PATHWAY[470038877$hsa04722:Neurotrophin signaling pathway]
SH2B adaptor protein 1,OMIM_DISEASE[520002058$Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity, 520004491$Six new loci associated with body mass index highlight a neuronal influence on body weight regulation]
SH2B adaptor protein 1,PIR_SUPERFAMILY[630021643$PIRSF028772:signaling mediator]
SH2B adaptor protein 1,SMART[760000205$SM00233:PH, 760000224$SM00252:SH2]
SH2B adaptor protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001397$SH2 domain]
SH2B adaptor protein 1,UP_SEQ_FEATURE[850060519$chain:SH2B adapter protein 1, 850104979$domain:PH, 850105346$domain:SH2, 850106258$modified residue, 850106259$mutagenesis site, 850112453$region of interest:Interaction with JAK2 (low-affinity binding; independent of JAK2 phosphorylation), 850112743$region of interest:Interaction with RAC1, 850114433$region of interest:Required for NGF signaling, 850114436$region of interest:Required for nuclear localization, 850114472$region of interest:Required for self-association, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SPRY domain containing 3,INTERPRO[450001654$IPR001870:B302 (SPRY)-like, 450003405$IPR003877:SPla/RYanodine receptor SPRY, 450016640$IPR018355:SPla/RYanodine receptor subgroup]
SPRY domain containing 3,SMART[760000394$SM00449:SPRY]
SPRY domain containing 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000825$kinase, 790001162$phosphoprotein, 790001301$receptor]
SPRY domain containing 3,UP_SEQ_FEATURE[850062251$chain:SPRY domain-containing protein 3, 850102507$compositionally biased region:Glu-rich, 850103078$domain:B30.2/SPRY, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
TBC1 domain family, member 14,COG_ONTOLOGY[90000073$General function prediction only]
TBC1 domain family, member 14,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 14,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 14,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000640$GTPase activation, 790001212$polymorphism]
TBC1 domain family, member 14,UP_SEQ_FEATURE[850063655$chain:TBC1 domain family member 14, 850105135$domain:Rab-GAP TBC, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
acid phosphatase 1, soluble,INTERPRO[450000089$IPR000106:Protein-tyrosine phosphatase/arsenate reductase, 450001874$IPR002115:Protein-tyrosine phosphatase, low molecular weight, mammalian, 450016186$IPR017867:Protein-tyrosine phosphatase, low molecular weight]
acid phosphatase 1, soluble,KEGG_PATHWAY[470038794$hsa00740:Riboflavin metabolism, 470038856$hsa04520:Adherens junction]
acid phosphatase 1, soluble,PIR_SUPERFAMILY[630001059$PIRSF000916:tyrosine-protein phosphatase, low molecular weight]
acid phosphatase 1, soluble,SMART[760000198$SM00226:LMWPc]
acid phosphatase 1, soluble,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001587$tyrosine-specific phosphatase]
acid phosphatase 1, soluble,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850029090$chain:Low molecular weight phosphotyrosine protein phosphatase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038883$hsa04912:GnRH signaling pathway, 470038905$hsa05215:Prostate cancer]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,PIR_SUPERFAMILY[630016200$PIRSF019614:cyclic AMP-dependent transcription factor, ATF4 type]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,SMART[760000306$SM00338:BRLZ]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000449$DNA binding, 790000466$dna-binding, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,UP_SEQ_FEATURE[850012981$chain:Cyclic AMP-dependent transcription factor ATF-4, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850105852$helix, 850106258$modified residue, 850112353$region of interest:Interaction with GABBR1, 850117294$sequence conflict, 850117295$sequence variant]
acyl-CoA synthetase long-chain family member 5,COG_ONTOLOGY[90000084$Lipid metabolism]
acyl-CoA synthetase long-chain family member 5,INTERPRO[450000762$IPR000873:AMP-dependent synthetase and ligase]
acyl-CoA synthetase long-chain family member 5,KEGG_PATHWAY[470038734$hsa00071:Fatty acid metabolism, 470038821$hsa03320:PPAR signaling pathway, 470038886$hsa04920:Adipocytokine signaling pathway]
acyl-CoA synthetase long-chain family member 5,PIR_SUPERFAMILY[630001719$PIRSF001551:human long-chain-fatty-acid-CoA ligase]
acyl-CoA synthetase long-chain family member 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000543$fatty acid metabolism, 790000859$ligase, 790000873$lipid metabolism, 790000899$magnesium, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001063$nucleotide-binding, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
acyl-CoA synthetase long-chain family member 5,UP_SEQ_FEATURE[850029027$chain:Long-chain-fatty-acid--CoA ligase 5, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
acyl-Coenzyme A dehydrogenase, short/branched chain,COG_ONTOLOGY[90000084$Lipid metabolism]
acyl-Coenzyme A dehydrogenase, short/branched chain,INTERPRO[450005523$IPR006089:Acyl-CoA dehydrogenase, conserved site, 450005524$IPR006090:Acyl-CoA oxidase/dehydrogenase, type 1, 450005525$IPR006091:Acyl-CoA oxidase/dehydrogenase, central region, 450005526$IPR006092:Acyl-CoA dehydrogenase, N-terminal, 450012383$IPR013764:Acyl-CoA oxidase/dehydrogenase, type1/2, C-terminal, 450012398$IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal]
acyl-Coenzyme A dehydrogenase, short/branched chain,KEGG_PATHWAY[470038734$hsa00071:Fatty acid metabolism, 470038748$hsa00280:Valine, leucine and isoleucine degradation]
acyl-Coenzyme A dehydrogenase, short/branched chain,OMIM_DISEASE[520000005$2-methylbutyrylglycinuria]
acyl-Coenzyme A dehydrogenase, short/branched chain,PIR_SUPERFAMILY[630000218$PIRSF000182:acyl-CoA dehydrogenase]
acyl-Coenzyme A dehydrogenase, short/branched chain,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000446$disease mutation, 790000537$FAD, 790000543$fatty acid metabolism, 790000559$Flavoprotein, 790000873$lipid metabolism, 790000969$mitochondrion, 790001092$oxidoreductase, 790001212$polymorphism, 790001550$transit peptide]
acyl-Coenzyme A dehydrogenase, short/branched chain,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000342$binding site:FAD; shared with dimeric partner, 850000555$binding site:Substrate, 850000574$binding site:Substrate; via amide nitrogen, 850000576$binding site:Substrate; via carbonyl oxygen, 850060670$chain:Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial, 850105852$helix, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850106291$nucleotide phosphate-binding region:FAD; shared with dimeric partner, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
ankyrin repeat and sterile alpha motif domain containing 3,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450001870$IPR002110:Ankyrin, 450012380$IPR013761:Sterile alpha motif-type]
ankyrin repeat and sterile alpha motif domain containing 3,SMART[760000220$SM00248:ANK, 760000399$SM00454:SAM]
ankyrin repeat and sterile alpha motif domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat and sterile alpha motif domain containing 3,UP_SEQ_FEATURE[850005336$chain:Ankyrin repeat and SAM domain-containing protein 3, 850102597$compositionally biased region:Ser-rich, 850105249$domain:SAM, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
calcium channel, voltage-dependent, N type, alpha 1B subunit,INTERPRO[450001840$IPR002077:Voltage-dependent calcium channel, alpha-1 subunit, 450004906$IPR005447:Voltage-dependent calcium channel, N-type, alpha-1 subunit, 450005268$IPR005821:Ion transport, 450013322$IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain, 450016534$IPR018249:EF-HAND 2]
calcium channel, voltage-dependent, N type, alpha 1B subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038880$hsa04742:Taste transduction, 470038887$hsa04930:Type II diabetes mellitus]
calcium channel, voltage-dependent, N type, alpha 1B subunit,PIR_SUPERFAMILY[630005588$PIRSF005657:voltage-gated calcium channel]
calcium channel, voltage-dependent, N type, alpha 1B subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, N type, alpha 1B subunit,UP_SEQ_FEATURE[850100540$chain:Voltage-dependent N-type calcium channel subunit alpha-1B, 850102574$compositionally biased region:Poly-His, 850102581$compositionally biased region:Poly-Ser, 850103571$domain:EF-hand, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111061$region of interest:Binding to the beta subunit, 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117295$sequence variant, 850117960$site:Calcium ion selectivity and permeability, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,INTERPRO[450000753$IPR000863:Sulfotransferase]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,UP_SEQ_FEATURE[850009410$chain:Carbohydrate sulfotransferase 15, 850105770$glycosylation site:N-linked (GlcNAc...), 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
carbonyl reductase 3,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
carbonyl reductase 3,KEGG_PATHWAY[470038780$hsa00590:Arachidonic acid metabolism]
carbonyl reductase 3,PIR_SUPERFAMILY[630000106$PIRSF000092:short-chain dehydrogenase]
carbonyl reductase 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism]
carbonyl reductase 3,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000461$binding site:NADP, 850000465$binding site:NADP; via carbonyl oxygen, 850000555$binding site:Substrate, 850009476$chain:Carbonyl reductase [NADPH] 3, 850105852$helix, 850106307$nucleotide phosphate-binding region:NADP, 850117295$sequence variant, 850118575$strand, 850118624$turn]
casein kinase 1, gamma 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
casein kinase 1, gamma 2,KEGG_PATHWAY[470038849$hsa04340:Hedgehog signaling pathway]
casein kinase 1, gamma 2,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein, 630031202$PIRSF501113:casein kinase 1]
casein kinase 1, gamma 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001642$wnt signaling pathway]
casein kinase 1, gamma 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009783$chain:Casein kinase I isoform gamma-2, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
caspase 8, apoptosis-related cysteine peptidase,BBID[10000037$150.caspase_and_NFKB_activation, 10000063$39.Deg_of_Chromosomal_DNA, 10000065$40.Deg_of_Chrom_DNA_TNF-ind_apoptosis, 10000067$44.Sig_Trans_TNFR1-DR3-DR4_DR5, 10000068$46.P13K_PTEN, 10000093$72.IAP_interaction_with_cell_death_pathways, 10000108$86.Apoptosis_Nematode&_Vert]
caspase 8, apoptosis-related cysteine peptidase,BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000060$h_ceramidePathway:Ceramide Signaling Pathway, 30000079$h_d4gdiPathway:D4-GDI Signaling Pathway, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000274$h_soddPathway:SODD/TNFR1 Signaling Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
caspase 8, apoptosis-related cysteine peptidase,INTERPRO[450001153$IPR001309:Peptidase C14, ICE, catalytic subunit p20, 450001658$IPR001875:Death effector, 450001895$IPR002138:Peptidase C14, caspase non-catalytic subunit p10, 450002131$IPR002398:Peptidase C14, caspase precursor p45, 450010009$IPR011029:DEATH-like, 450010431$IPR011600:Peptidase C14, caspase catalytic, 450014334$IPR015917:Peptidase C14, caspase precursor p45, core, 450014488$IPR016129:Peptidase C14, ICE, catalytic subunit p20, active site]
caspase 8, apoptosis-related cysteine peptidase,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway, 470038843$hsa04210:Apoptosis, 470038862$hsa04620:Toll-like receptor signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway, 470038864$hsa04622:RIG-I-like receptor signaling pathway, 470038891$hsa05010:Alzheimer's disease, 470038894$hsa05016:Huntington's disease, 470038899$hsa05200:Pathways in cancer, 470038923$hsa05416:Viral myocarditis]
caspase 8, apoptosis-related cysteine peptidase,OMIM_DISEASE[520000487$Autoimmune lymphoproliferative syndrome, type IIB, 520000688$Breast cancer, protection against, 520002293$Hepatocellular carcinoma, somatic, 520002967$Lung cancer, protection against]
caspase 8, apoptosis-related cysteine peptidase,PIR_SUPERFAMILY[630029212$PIRSF037643:Casp8 and Fadd-like apoptosis regulator/caspase, types 8/10, 630030828$PIRSF500656:caspase-8]
caspase 8, apoptosis-related cysteine peptidase,SMART[760000023$SM00031:DED, 760000102$SM00115:CASc]
caspase 8, apoptosis-related cysteine peptidase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000743$hydrolase, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001509$thiol protease, 790001652$zymogen]
caspase 8, apoptosis-related cysteine peptidase,UP_SEQ_FEATURE[850009845$chain:Caspase-8 subunit p10, 850009847$chain:Caspase-8 subunit p18, 850103512$domain:DED 1, 850103513$domain:DED 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
catenin (cadherin-associated protein), delta 1,INTERPRO[450000194$IPR000225:Armadillo, 450010814$IPR011989:Armadillo-like helical]
catenin (cadherin-associated protein), delta 1,KEGG_PATHWAY[470038856$hsa04520:Adherens junction, 470038873$hsa04670:Leukocyte transendothelial migration]
catenin (cadherin-associated protein), delta 1,SMART[760000159$SM00185:ARM]
catenin (cadherin-associated protein), delta 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001642$wnt signaling pathway]
catenin (cadherin-associated protein), delta 1,UP_SEQ_FEATURE[850009899$chain:Catenin delta-1, 850106258$modified residue, 850115674$repeat:ARM 1, 850115675$repeat:ARM 10, 850115683$repeat:ARM 2, 850115684$repeat:ARM 3, 850115685$repeat:ARM 4, 850115687$repeat:ARM 5, 850115688$repeat:ARM 6, 850115689$repeat:ARM 7, 850115690$repeat:ARM 8, 850115691$repeat:ARM 9, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
chemokine (C-X-C motif) ligand 17,INTERPRO[450016352$IPR018048:Small chemokine, C-X-C, conserved site]
chemokine (C-X-C motif) ligand 17,SP_PIR_KEYWORDS[790000081$angiogenesis, 790000291$chemotaxis, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000445$direct protein sequencing, 790000447$disulfide bond, 790001363$Secreted, 790001405$signal]
chemokine (C-X-C motif) ligand 17,UP_SEQ_FEATURE[850100110$chain:VEGF co-regulated chemokine 1, 850102883$disulfide bond, 850106259$mutagenesis site, 850117814$signal peptide]
chibby homolog 3 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome]
chibby homolog 3 (Drosophila),UP_SEQ_FEATURE[850045379$chain:Protein chibby homolog 3]
chitinase 1 (chitotriosidase),INTERPRO[450001076$IPR001223:Glycoside hydrolase, family 18, catalytic domain, 450001403$IPR001579:Glycoside hydrolase, chitinase active site, 450002273$IPR002557:Chitin binding protein, peritrophin-A, 450010425$IPR011583:Chitinase II, 450012395$IPR013781:Glycoside hydrolase, subgroup, catalytic core]
chitinase 1 (chitotriosidase),KEGG_PATHWAY[470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
chitinase 1 (chitotriosidase),OMIM_DISEASE[520000982$Chitotriosidase deficiency]
chitinase 1 (chitotriosidase),PIR_SUPERFAMILY[630001210$PIRSF001061:chitinase-like protein]
chitinase 1 (chitotriosidase),SMART[760000437$SM00494:ChtBD2, 760000551$SM00636:Glyco_18]
chitinase 1 (chitotriosidase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000232$carbohydrate metabolism, 790000293$Chitin degradation, 790000294$Chitin-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000617$glycosidase, 790000743$hydrolase, 790000897$lysosome, 790001212$polymorphism, 790001216$polysaccharide degradation, 790001363$Secreted, 790001405$signal]
chitinase 1 (chitotriosidase),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850011055$chain:Chitotriosidase-1, 850102883$disulfide bond, 850103339$domain:Chitin-binding type-2, 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
chromodomain helicase DNA binding protein 1,INTERPRO[450000283$IPR000330:SNF2-related, 450000831$IPR000953:Chromo domain, 450002185$IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
chromodomain helicase DNA binding protein 1,SMART[760000268$SM00298:CHROMO, 760000432$SM00487:DEXDc]
chromodomain helicase DNA binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
chromodomain helicase DNA binding protein 1,UP_SEQ_FEATURE[850011380$chain:Chromodomain-helicase-DNA-binding protein 1, 850102597$compositionally biased region:Ser-rich, 850103362$domain:Chromo 1, 850103363$domain:Chromo 2, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110239$region of interest:3 X 5 AA repeats of H-S-D-H-R, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850117294$sequence conflict, 850117295$sequence variant, 850117387$short sequence motif:DEAH box, 850118574$splice variant, 850118575$strand, 850118624$turn]
chromosome 10 open reading frame 26,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 10 open reading frame 26,UP_SEQ_FEATURE[850036312$chain:Outcome predictor in acute leukemia 1, 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
chromosome 16 open reading frame 13,INTERPRO[450009407$IPR010342:Protein of unknown function DUF938]
chromosome 16 open reading frame 13,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein]
chromosome 16 open reading frame 13,UP_SEQ_FEATURE[850097795$chain:UPF0585 protein C16orf13, 850106258$modified residue, 850118574$splice variant]
chromosome 20 open reading frame 27,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing]
chromosome 20 open reading frame 27,UP_SEQ_FEATURE[850098207$chain:UPF0687 protein C20orf27, 850117294$sequence conflict]
chromosome 3 open reading frame 20,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
chromosome 3 open reading frame 20,UP_SEQ_FEATURE[850074069$chain:Uncharacterized protein C3orf20, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
chromosome 5 open reading frame 48,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 5 open reading frame 48,UP_SEQ_FEATURE[850074270$chain:Uncharacterized protein C5orf48]
chromosome 6 open reading frame 203,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
chromosome 6 open reading frame 203,UP_SEQ_FEATURE[850074365$chain:Uncharacterized protein C6orf203, 850106258$modified residue]
chromosome 6 open reading frame 59; ripply2 homolog (zebrafish),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001065$nucleus]
chromosome 6 open reading frame 59; ripply2 homolog (zebrafish),UP_SEQ_FEATURE[850047510$chain:Protein ripply2, 850055317$chain:Putative uncharacterized protein C6orf59, 850114539$region of interest:Ripply homology domain, 850117764$short sequence motif:WRPW motif, 850118574$splice variant]
cryptochrome 2 (photolyase-like),BIOCARTA[30000064$h_circadianPathway:Circadian Rhythms]
cryptochrome 2 (photolyase-like),COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
cryptochrome 2 (photolyase-like),INTERPRO[450004570$IPR005101:DNA photolyase, FAD-binding/Cryptochrome, C-terminal, 450005488$IPR006050:DNA photolyase, N-terminal, 450013180$IPR014729:Rossmann-like alpha/beta/alpha sandwich fold, 450016674$IPR018394:Cryptochrome/DNA photolyase, class 1 conserved site, C-terminal]
cryptochrome 2 (photolyase-like),KEGG_PATHWAY[470038875$hsa04710:Circadian rhythm]
cryptochrome 2 (photolyase-like),PIR_SUPERFAMILY[630001541$PIRSF001387:deoxyribodipyrimidine photo-lyase]
cryptochrome 2 (photolyase-like),SP_PIR_KEYWORDS[790000182$biological rhythms, 790000312$chromophore, 790000356$complete proteome, 790000407$cytoplasm, 790000537$FAD, 790000559$Flavoprotein, 790000891$lyase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001172$photoreceptor protein, 790001301$receptor, 790001307$repressor, 790001377$sensory transduction, 790001539$Transcription, 790001543$transcription regulation]
cryptochrome 2 (photolyase-like),UP_SEQ_FEATURE[850012771$chain:Cryptochrome-2, 850103532$domain:DNA photolyase, 850106258$modified residue, 850111659$region of interest:FAD-binding, 850114316$region of interest:Required for inhibition of CLOCK-ARNTL- mediated transcription, 850117294$sequence conflict]
cyclin L2; chemokine (C-C motif) receptor 6,BBID[10000030$14.chemokine_receptor-ligand]
cyclin L2; chemokine (C-C motif) receptor 6,COG_ONTOLOGY[90000030$Cell division and chromosome partitioning / Transcription / DNA replication, recombination, and repair]
cyclin L2; chemokine (C-C motif) receptor 6,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000305$IPR000355:Chemokine receptor, 450003583$IPR004067:C-C chemokine receptor, type 6, 450006082$IPR006670:Cyclin, 450006083$IPR006671:Cyclin, N-terminal, 450012382$IPR013763:Cyclin-related, 450013871$IPR015429:Transcription regulator cyclin, 450015380$IPR017060:Cyclin L, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
cyclin L2; chemokine (C-C motif) receptor 6,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
cyclin L2; chemokine (C-C motif) receptor 6,OMIM_DISEASE[520001992$Genome-wide assocation defines more than 30 distinct susceptibility loci for Crohn's disease]
cyclin L2; chemokine (C-C motif) receptor 6,PIR_SUPERFAMILY[630028057$PIRSF036580:cyclin, L type, 630028058$PIRSF036580:Cyclin_L, 630030051$PIRSF038545:chemokine receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
cyclin L2; chemokine (C-C motif) receptor 6,SMART[760000337$SM00385:CYCLIN]
cyclin L2; chemokine (C-C motif) receptor 6,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000389$cyclin, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001301$receptor, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
cyclin L2; chemokine (C-C motif) receptor 6,UP_SEQ_FEATURE[850008593$chain:C-C chemokine receptor type 6, 850013136$chain:Cyclin-L2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850111374$region of interest:Cyclin-like 1, 850111375$region of interest:Cyclin-like 2, 850114560$region of interest:RS, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cyclin-dependent kinase 2 associated protein 2,INTERPRO[450015588$IPR017266:Cyclin-dependent kinase 2-associated protein 2, 450017433$IPR019187:Cyclin-dependent kinase 2-associated protein]
cyclin-dependent kinase 2 associated protein 2,PIR_SUPERFAMILY[630029280$PIRSF037709:CDK2-associated_p2, 630029281$PIRSF037709:cyclin-dependent kinase 2-associated protein 2]
cyclin-dependent kinase 2 associated protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000825$kinase]
cyclin-dependent kinase 2 associated protein 2,UP_SEQ_FEATURE[850013068$chain:Cyclin-dependent kinase 2-associated protein 2]
cytoplasmic polyadenylation element binding protein 4,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
cytoplasmic polyadenylation element binding protein 4,SMART[760000328$SM00360:RRM]
cytoplasmic polyadenylation element binding protein 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
cytoplasmic polyadenylation element binding protein 4,UP_SEQ_FEATURE[850014053$chain:Cytoplasmic polyadenylation element- binding protein 4, 850102540$compositionally biased region:His-rich, 850102573$compositionally biased region:Poly-Gly, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
docking protein 3,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450002137$IPR002404:Insulin receptor substrate-1, PTB, 450010818$IPR011993:Pleckstrin homology-type]
docking protein 3,SMART[760000205$SM00233:PH, 760000280$SM00310:PTBI]
docking protein 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
docking protein 3,UP_SEQ_FEATURE[850016215$chain:Docking protein 3, 850102586$compositionally biased region:Pro-rich, 850104482$domain:IRS-type PTB, 850104979$domain:PH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dopamine receptor D4,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000811$IPR000929:Dopamine receptor, 450001938$IPR002185:Dopamine D4 receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
dopamine receptor D4,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
dopamine receptor D4,OMIM_DISEASE[520000462$Attention deficit-hyperactivity disorder, 520000492$Autonomic nervous system dysfunction, 520003690$Novelty seeking personality, 520003933$Parkinson disease, protection against]
dopamine receptor D4,PIR_SUPERFAMILY[630030058$PIRSF038553:D2-like dopamine receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
dopamine receptor D4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001026$neurotransmitter receptor, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
dopamine receptor D4,UP_SEQ_FEATURE[850014153$chain:D(4) dopamine receptor, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850110632$region of interest:7 X 16 AA approximate tandem repeats of [PA]-A-P-G-L-P-[PQR]-[DG]-P-C-G-P-D-C-A- P, 850115269$repeat:1; approximate, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115567$repeat:7; approximate, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
dullard homolog (Xenopus laevis),INTERPRO[450003783$IPR004274:NLI interacting factor, 450010773$IPR011948:Dullard-like phosphatase domain]
dullard homolog (Xenopus laevis),SMART[760000514$SM00577:CPDc]
dullard homolog (Xenopus laevis),SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001261$protein phosphatase, 790001555$transmembrane]
dullard homolog (Xenopus laevis),UP_SEQ_FEATURE[850060161$chain:Serine/threonine-protein phosphatase dullard, 850103756$domain:FCP1 homology, 850106259$mutagenesis site, 850117295$sequence variant, 850118623$transmembrane region]
dynactin 4 (p62),INTERPRO[450007864$IPR008603:Dynactin p62]
dynactin 4 (p62),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynactin 4 (p62),SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
dynactin 4 (p62),UP_SEQ_FEATURE[850016481$chain:Dynactin subunit 4, 850106258$modified residue, 850117295$sequence variant]
embigin homolog (mouse),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450012396$IPR013783:Immunoglobulin-like fold]
embigin homolog (mouse),SMART[760000357$SM00409:IG]
embigin homolog (mouse),SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
embigin homolog (mouse),UP_SEQ_FEATURE[850017161$chain:Embigin, 850102883$disulfide bond, 850104408$domain:Ig-like V-type 1, 850104409$domain:Ig-like V-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
enkurin, TRPC channel interacting protein,SP_PIR_KEYWORDS[790000218$calmodulin-binding, 790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000557$flagellum, 790001399$sh3-binding]
enkurin, TRPC channel interacting protein,UP_SEQ_FEATURE[850017485$chain:Enkurin, 850104439$domain:IQ, 850117711$short sequence motif:SH3-binding]
family with sequence similarity 53, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
family with sequence similarity 53, member B,UP_SEQ_FEATURE[850046005$chain:Protein FAM53B, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
family with sequence similarity 59, member B,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM]
family with sequence similarity 59, member B,SMART[760000399$SM00454:SAM]
family with sequence similarity 59, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 59, member B,UP_SEQ_FEATURE[850046018$chain:Protein FAM59B, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850105249$domain:SAM, 850117294$sequence conflict, 850118574$splice variant]
family with sequence similarity 76, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome]
family with sequence similarity 76, member A,UP_SEQ_FEATURE[850046057$chain:Protein FAM76A, 850102581$compositionally biased region:Poly-Ser, 850118574$splice variant]
fatty acid amide hydrolase 2,COG_ONTOLOGY[90000125$Translation, ribosomal structure and biogenesis]
fatty acid amide hydrolase 2,INTERPRO[450000102$IPR000120:Amidase signature enzyme]
fatty acid amide hydrolase 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790000919$membrane, 790001555$transmembrane]
fatty acid amide hydrolase 2,UP_SEQ_FEATURE[850000004$active site:Acyl-ester intermediate, 850000011$active site:Charge relay system, 850019082$chain:Fatty-acid amide hydrolase 2, 850102576$compositionally biased region:Poly-Leu, 850117294$sequence conflict, 850118623$transmembrane region]
feline leukemia virus subgroup C cellular receptor family, member 2,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
feline leukemia virus subgroup C cellular receptor family, member 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
feline leukemia virus subgroup C cellular receptor family, member 2,UP_SEQ_FEATURE[850019160$chain:Feline leukemia virus subgroup C receptor-related protein 2, 850102572$compositionally biased region:Poly-Glu, 850110728$region of interest:8 X 6 AA tandem repeats of P-S-[VS]-S- [VIAG]-[HNP], 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115551$repeat:6; approximate, 850115567$repeat:7; approximate, 850115571$repeat:8, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
fibroblast growth factor binding protein 2,INTERPRO[450009564$IPR010510:FGF binding 1]
fibroblast growth factor binding protein 2,PIR_SUPERFAMILY[630019049$PIRSF023927:fibroblast growth factor-binding protein]
fibroblast growth factor binding protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000633$Growth factor binding, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
fibroblast growth factor binding protein 2,UP_SEQ_FEATURE[850019422$chain:Fibroblast growth factor-binding protein 2, 850102883$disulfide bond, 850117295$sequence variant, 850117814$signal peptide]
forkhead box F1,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
forkhead box F1,UP_SEQ_FEATURE[850019858$chain:Forkhead box protein F1, 850102914$DNA-binding region:Fork-head]
glutamate receptor, metabotropic 4,INTERPRO[450000138$IPR000162:GPCR, family 3, metabotropic glutamate receptor, 450000290$IPR000337:GPCR, family 3, 450001579$IPR001786:GPCR, family 3, metabotropic glutamate receptor 4, 450001618$IPR001828:Extracellular ligand-binding receptor, 450010362$IPR011500:GPCR, family 3, nine cysteines region, 450016286$IPR017978:GPCR, family 3, C-terminal, 450016287$IPR017979:GPCR, family 3, conserved site]
glutamate receptor, metabotropic 4,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038880$hsa04742:Taste transduction]
glutamate receptor, metabotropic 4,PIR_SUPERFAMILY[630005529$PIRSF005608:metabotropic glutamate receptors and related, 630031170$PIRSF501044:metabotropic glutamate receptors]
glutamate receptor, metabotropic 4,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
glutamate receptor, metabotropic 4,UP_SEQ_FEATURE[850031239$chain:Metabotropic glutamate receptor 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
gonadotropin-releasing hormone receptor,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450001469$IPR001658:Gonadotrophin releasing hormone receptor, 450014128$IPR015693:Gonadotropin-releasing hormone receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
gonadotropin-releasing hormone receptor,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038883$hsa04912:GnRH signaling pathway]
gonadotropin-releasing hormone receptor,OMIM_DISEASE[520001891$Fertile eunuch syndrome, 520002517$Hypogonadotropic hypogonadism]
gonadotropin-releasing hormone receptor,PIR_SUPERFAMILY[630030080$PIRSF038576:gonadotropin-releasing hormone receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
gonadotropin-releasing hormone receptor,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000709$hormone receptor, 790000751$hypogonadotropic hypogonadism, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
gonadotropin-releasing hormone receptor,UP_SEQ_FEATURE[850022273$chain:Gonadotropin-releasing hormone receptor, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
guanylate binding protein 2, interferon-inducible,INTERPRO[450002808$IPR003191:Guanylate-binding protein, C-terminal, 450014315$IPR015894:Guanylate-binding protein, N-terminal]
guanylate binding protein 2, interferon-inducible,PIR_SUPERFAMILY[630005479$PIRSF005552:guanine nucleotide-binding protein 1]
guanylate binding protein 2, interferon-inducible,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001212$polymorphism, 790001236$prenylation]
guanylate binding protein 2, interferon-inducible,UP_SEQ_FEATURE[850026454$chain:Interferon-induced guanylate-binding protein 2, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant]
guanylate binding protein 5,INTERPRO[450002808$IPR003191:Guanylate-binding protein, C-terminal, 450014315$IPR015894:Guanylate-binding protein, N-terminal]
guanylate binding protein 5,PIR_SUPERFAMILY[630005479$PIRSF005552:guanine nucleotide-binding protein 1]
guanylate binding protein 5,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001212$polymorphism, 790001236$prenylation]
guanylate binding protein 5,UP_SEQ_FEATURE[850022801$chain:Guanylate-binding protein 5, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117295$sequence variant]
hepatoma-derived growth factor-related protein 2,INTERPRO[450000267$IPR000313:PWWP]
hepatoma-derived growth factor-related protein 2,SMART[760000264$SM00293:PWWP]
hepatoma-derived growth factor-related protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
hepatoma-derived growth factor-related protein 2,UP_SEQ_FEATURE[850023521$chain:Hepatoma-derived growth factor-related protein 2, 850102404$compositionally biased region:Arg-rich, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850105126$domain:PWWP, 850105852$helix, 850106258$modified residue, 850118574$splice variant, 850118575$strand, 850118624$turn]
histone cluster 1, H1a,INTERPRO[450005266$IPR005818:Histone H1/H5, 450005267$IPR005819:Histone H5, 450010816$IPR011991:Winged helix repressor DNA-binding]
histone cluster 1, H1a,PIR_SUPERFAMILY[630029831$PIRSF038219:histone H1]
histone cluster 1, H1a,SMART[760000466$SM00526:H15]
histone cluster 1, H1a,SP_PIR_KEYWORDS[790000012$acetylation, 790000315$chromosomal protein, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
histone cluster 1, H1a,UP_SEQ_FEATURE[850023948$chain:Histone H1.1, 850106258$modified residue, 850117295$sequence variant]
inhibitor of growth family, member 4,COG_ONTOLOGY[90000042$Chromatin structure and dynamics]
inhibitor of growth family, member 4,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
inhibitor of growth family, member 4,PIR_SUPERFAMILY[630014443$PIRSF017781:uncharacterized conserved protein]
inhibitor of growth family, member 4,SMART[760000221$SM00249:PHD]
inhibitor of growth family, member 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000258$cell cycle, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001580$tumor suppressor, 790001648$zinc, 790001651$zinc-finger]
inhibitor of growth family, member 4,UP_SEQ_FEATURE[850025778$chain:Inhibitor of growth protein 4, 850105852$helix, 850106258$modified residue, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118877$zinc finger region:PHD-type]
interferon induced transmembrane protein 2 (1-8D),INTERPRO[450006944$IPR007593:Interferon-induced transmembrane protein]
interferon induced transmembrane protein 2 (1-8D),PIR_SUPERFAMILY[630013367$PIRSF016581:interferon-induced transmembrane protein]
interferon induced transmembrane protein 2 (1-8D),SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
interferon induced transmembrane protein 2 (1-8D),UP_SEQ_FEATURE[850026465$chain:Interferon-induced transmembrane protein 2, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
interleukin enhancer binding factor 3, 90kDa,INTERPRO[450001016$IPR001159:Double-stranded RNA binding, 450005981$IPR006561:DZF]
interleukin enhancer binding factor 3, 90kDa,SMART[760000326$SM00358:DSRM, 760000509$SM00572:DZF]
interleukin enhancer binding factor 3, 90kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790000953$methylation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
interleukin enhancer binding factor 3, 90kDa,UP_SEQ_FEATURE[850026487$chain:Interleukin enhancer-binding factor 3, 850102424$compositionally biased region:Arg/Gly-rich, 850102573$compositionally biased region:Poly-Gly, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850103567$domain:DZF, 850106258$modified residue, 850112712$region of interest:Interaction with PRMT1, 850117294$sequence conflict, 850117295$sequence variant, 850117325$short sequence motif:Bipartite nuclear localization signal, 850118574$splice variant]
intermediate filament family orphan 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament]
intermediate filament family orphan 1,UP_SEQ_FEATURE[850026601$chain:Intermediate filament family orphan 1, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850117294$sequence conflict, 850118574$splice variant]
keratin 20,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002605$IPR002957:Keratin, type I, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 20,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 20,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000788$Intermediate filament, 790000821$keratin, 790001162$phosphoprotein, 790001212$polymorphism]
keratin 20,UP_SEQ_FEATURE[850027182$chain:Keratin, type I cytoskeletal 20, 850106258$modified residue, 850106259$mutagenesis site, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118033$site:Cleavage; by caspases]
keratin 9,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002605$IPR002957:Keratin, type I, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 9,OMIM_DISEASE[520001731$Epidermolytic palmoplantar keratoderma]
keratin 9,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 9,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000788$Intermediate filament, 790000821$keratin, 790001101$palmoplantar keratoderma]
keratin 9,UP_SEQ_FEATURE[850027193$chain:Keratin, type I cytoskeletal 9, 850102573$compositionally biased region:Poly-Gly, 850106259$mutagenesis site, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant]
leucine zipper, down-regulated in cancer 1-like,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome]
leucine zipper, down-regulated in cancer 1-like,UP_SEQ_FEATURE[850046659$chain:Protein LDOC1L]
leucine-rich repeats and WD repeat domain containing 1,COG_ONTOLOGY[90000070$Function unknown]
leucine-rich repeats and WD repeat domain containing 1,INTERPRO[450001429$IPR001611:Leucine-rich repeat, 450001490$IPR001680:WD40 repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
leucine-rich repeats and WD repeat domain containing 1,SMART[760000289$SM00320:WD40, 760000333$SM00369:LRR_TYP]
leucine-rich repeats and WD repeat domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000853$leucine-rich repeat, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
leucine-rich repeats and WD repeat domain containing 1,UP_SEQ_FEATURE[850028331$chain:Leucine-rich repeat and WD repeat- containing protein 1, 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5]
maestro,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism]
maestro,UP_SEQ_FEATURE[850046784$chain:Protein maestro, 850116139$repeat:HEAT, 850117295$sequence variant]
major facilitator superfamily domain containing 4,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
major facilitator superfamily domain containing 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
major facilitator superfamily domain containing 4,UP_SEQ_FEATURE[850030096$chain:Major facilitator superfamily domain- containing protein 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
major histocompatibility complex, class I-related,INTERPRO[450000912$IPR001039:MHC class I, alpha chain, alpha1 and alpha2, 450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003158$IPR003597:Immunoglobulin C1-set, 450006486$IPR007110:Immunoglobulin-like, 450010088$IPR011161:MHC class I-like antigen recognition, 450012396$IPR013783:Immunoglobulin-like fold]
major histocompatibility complex, class I-related,PIR_SUPERFAMILY[630002127$PIRSF001990:class I histocompatibility antigen]
major histocompatibility complex, class I-related,SMART[760000355$SM00407:IGc1]
major histocompatibility complex, class I-related,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000763$immune response, 790000768$Immunoglobulin domain, 790000919$membrane, 790000955$mhc i, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
major histocompatibility complex, class I-related,UP_SEQ_FEATURE[850030123$chain:Major histocompatibility complex class I- related gene protein, 850102883$disulfide bond, 850104352$domain:Ig-like C1-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850110907$region of interest:Alpha-1, 850110908$region of interest:Alpha-2, 850110909$region of interest:Alpha-3, 850111296$region of interest:Connecting peptide, 850113269$region of interest:Ligand-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
melanocortin 2 receptor accessory protein,OMIM_DISEASE[520002122$Glucocorticoid deficiency 2]
melanocortin 2 receptor accessory protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000919$membrane, 790001555$transmembrane]
melanocortin 2 receptor accessory protein,UP_SEQ_FEATURE[850030999$chain:Melanocortin-2 receptor accessory protein, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
minichromosome maintenance complex component 2,INTERPRO[450001062$IPR001208:DNA-dependent ATPase MCM, 450007382$IPR008045:MCM protein 2, 450011038$IPR012340:Nucleic acid-binding, OB-fold, 450016797$IPR018525:DNA-dependent ATPase MCM, conserved site]
minichromosome maintenance complex component 2,KEGG_PATHWAY[470038817$hsa03030:DNA replication, 470038834$hsa04110:Cell cycle]
minichromosome maintenance complex component 2,SMART[760000318$SM00350:MCM]
minichromosome maintenance complex component 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000258$cell cycle, 790000356$complete proteome, 790000460$dna replication, 790000466$dna-binding, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
minichromosome maintenance complex component 2,UP_SEQ_FEATURE[850015813$chain:DNA replication licensing factor mcm2, 850104762$domain:MCM, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850112579$region of interest:Interaction with MYST2, 850117294$sequence conflict, 850117295$sequence variant, 850118762$zinc finger region:C4-type]
mitochondrial ribosomal protein L48,INTERPRO[450001634$IPR001848:Ribosomal protein S10]
mitochondrial ribosomal protein L48,PIR_SUPERFAMILY[630011295$PIRSF013605:uncharacterized conserved protein related to ribosomal protein S10/S20]
mitochondrial ribosomal protein L48,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001550$transit peptide]
mitochondrial ribosomal protein L48,UP_SEQ_FEATURE[850001793$chain:39S ribosomal protein L48, mitochondrial, 850102577$compositionally biased region:Poly-Lys, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
myosin, heavy chain 11, smooth muscle,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450001427$IPR001609:Myosin head, motor region, 450002582$IPR002928:Myosin tail, 450003529$IPR004009:Myosin, N-terminal, SH3-like]
myosin, heavy chain 11, smooth muscle,KEGG_PATHWAY[470038845$hsa04270:Vascular smooth muscle contraction, 470038857$hsa04530:Tight junction, 470038923$hsa05416:Viral myocarditis]
myosin, heavy chain 11, smooth muscle,OMIM_DISEASE[520000350$Aortic aneurysm, familial thoracic 4]
myosin, heavy chain 11, smooth muscle,PIR_SUPERFAMILY[630002451$PIRSF002328:myosin heavy chain]
myosin, heavy chain 11, smooth muscle,SMART[760000009$SM00015:IQ, 760000214$SM00242:MYSc]
myosin, heavy chain 11, smooth muscle,SP_PIR_KEYWORDS[790000019$actin-binding, 790000106$aortic aneurysm, 790000134$ATP, 790000138$atp-binding, 790000218$calmodulin-binding, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000953$methylation, 790000986$motor protein, 790000997$muscle protein, 790001002$myosin, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001417$smooth muscle, 790001504$thick filament]
myosin, heavy chain 11, smooth muscle,UP_SEQ_FEATURE[850033034$chain:Myosin-11, 850104439$domain:IQ, 850104809$domain:Myosin head-like, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110834$region of interest:Actin-binding, 850111176$region of interest:Carboxyl-terminal, 850117294$sequence conflict, 850117295$sequence variant]
myosin, heavy chain 7, cardiac muscle, beta,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450001427$IPR001609:Myosin head, motor region, 450002582$IPR002928:Myosin tail, 450003529$IPR004009:Myosin, N-terminal, SH3-like, 450014086$IPR015650:Heavy chain of Myosin]
myosin, heavy chain 7, cardiac muscle, beta,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction, 470038857$hsa04530:Tight junction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038922$hsa05414:Dilated cardiomyopathy, 470038923$hsa05416:Viral myocarditis]
myosin, heavy chain 7, cardiac muscle, beta,OMIM_DISEASE[520000781$Cardiomyopathy, dilated, 1S, 520000796$Cardiomyopathy, familial hypertrophic, 1, 520000888$Central core disease, one form, 520003502$Myopathy, Laing distal, 520003506$Myopathy, myosin storage, 520004388$Scapuloperoneal syndrome, myopathic type]
myosin, heavy chain 7, cardiac muscle, beta,SMART[760000009$SM00015:IQ, 760000214$SM00242:MYSc]
myosin, heavy chain 7, cardiac muscle, beta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000019$actin-binding, 790000138$atp-binding, 790000218$calmodulin-binding, 790000245$Cardiomyopathy, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000811$isopeptide bond, 790000953$methylation, 790000986$motor protein, 790000997$muscle protein, 790001002$myosin, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001504$thick filament, 790001592$ubl conjugation]
myosin, heavy chain 7, cardiac muscle, beta,UP_SEQ_FEATURE[850033046$chain:Myosin-7, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850104439$domain:IQ, 850104809$domain:Myosin head-like, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110834$region of interest:Actin-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
myozenin 3,INTERPRO[450007715$IPR008438:Calcineurin-binding]
myozenin 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism]
myozenin 3,UP_SEQ_FEATURE[850033115$chain:Myozenin-3, 850111039$region of interest:Binding to ACTN2, 850111040$region of interest:Binding to ACTN2, PPP3CA and TCAP, 850111047$region of interest:Binding to FLNC, 850117295$sequence variant, 850118574$splice variant]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,INTERPRO[450009680$IPR010630:Neuroblastoma breakpoint family]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,UP_SEQ_FEATURE[850033937$chain:Neuroblastoma breakpoint family member 1, 850033938$chain:Neuroblastoma breakpoint family member 10, 850033939$chain:Neuroblastoma breakpoint family member 11, 850033940$chain:Neuroblastoma breakpoint family member 12, 850033941$chain:Neuroblastoma breakpoint family member 14, 850033942$chain:Neuroblastoma breakpoint family member 15, 850033944$chain:Neuroblastoma breakpoint family member 20, 850033950$chain:Neuroblastoma breakpoint family member 8, 850033951$chain:Neuroblastoma breakpoint family member 9, 850102566$compositionally biased region:Poly-Arg, 850102572$compositionally biased region:Poly-Glu, 850104832$domain:NBPF 1, 850104833$domain:NBPF 10, 850104834$domain:NBPF 2, 850104835$domain:NBPF 3, 850104836$domain:NBPF 4, 850104837$domain:NBPF 5, 850104838$domain:NBPF 6, 850104839$domain:NBPF 7, 850104840$domain:NBPF 8, 850104841$domain:NBPF 9, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
nuclear receptor subfamily 2, group C, member 1,INTERPRO[450000278$IPR000324:Vitamin D receptor, 450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
nuclear receptor subfamily 2, group C, member 1,PIR_SUPERFAMILY[630002644$PIRSF002526:orphan nuclear receptor TR2/TR4]
nuclear receptor subfamily 2, group C, member 1,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
nuclear receptor subfamily 2, group C, member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
nuclear receptor subfamily 2, group C, member 1,UP_SEQ_FEATURE[850035047$chain:Nuclear receptor subfamily 2 group C member 1, 850102946$DNA-binding region:Nuclear receptor, 850106258$modified residue, 850111977$region of interest:Important for binding to NRIP1, but by itself is not sufficient for this interaction, 850117294$sequence conflict, 850118574$splice variant, 850118866$zinc finger region:NR C4-type]
nucleoporin 98kDa,INTERPRO[450006599$IPR007230:Peptidase S59, nucleoporin]
nucleoporin 98kDa,OMIM_DISEASE[520002859$Leukemia, lymphycytic, acute T-cell]
nucleoporin 98kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000919$membrane, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001554$translocation, 790001558$transport]
nucleoporin 98kDa,UP_SEQ_FEATURE[850035011$chain:Nuclear pore complex protein Nup96, 850035012$chain:Nuclear pore complex protein Nup98, 850102537$compositionally biased region:Gly/Thr-rich, 850102572$compositionally biased region:Poly-Glu, 850104971$domain:Peptidase S59, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117920$site:Breakpoint for translocation to form NUP98-PHF23 oncogene, 850118574$splice variant, 850118575$strand, 850118624$turn]
nucleotide binding protein 2 (MinD homolog, E. coli),COG_ONTOLOGY[90000036$Cell motility]
nucleotide binding protein 2 (MinD homolog, E. coli),INTERPRO[450000701$IPR000808:Mrp, conserved site, 450017828$IPR019591:ATPase-like, ParA/MinD]
nucleotide binding protein 2 (MinD homolog, E. coli),PIR_SUPERFAMILY[630005290$PIRSF005364:nucleotide-binding protein, Mrp/NBP35 type]
nucleotide binding protein 2 (MinD homolog, E. coli),SP_PIR_KEYWORDS[790000005$4fe-4s, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000802$iron, 790000806$iron-sulfur, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001212$polymorphism]
nucleotide binding protein 2 (MinD homolog, E. coli),UP_SEQ_FEATURE[850014099$chain:Cytosolic Fe-S cluster assembly factor NUBP2, 850106068$metal ion-binding site:Iron-sulfur (4Fe-4S), 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
nurim (nuclear envelope membrane protein),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001065$nucleus, 790001555$transmembrane]
nurim (nuclear envelope membrane protein),UP_SEQ_FEATURE[850035377$chain:Nurim, 850102552$compositionally biased region:Leu-rich, 850102576$compositionally biased region:Poly-Leu, 850118574$splice variant, 850118623$transmembrane region]
olfactory receptor, family 2, subfamily AG, member 2,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 2, subfamily AG, member 2,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 2, subfamily AG, member 2,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 2, subfamily AG, member 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 2, subfamily AG, member 2,UP_SEQ_FEATURE[850035660$chain:Olfactory receptor 2AG2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 2, subfamily G, member 6,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450013984$IPR015544:Olfactory receptor MOR256, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 2, subfamily G, member 6,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 2, subfamily G, member 6,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 2, subfamily G, member 6,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 2, subfamily G, member 6,UP_SEQ_FEATURE[850035676$chain:Olfactory receptor 2G6, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 4, subfamily F, member 29; olfactory receptor, family 4, subfamily F, member 3; olfactory receptor, family 4, subfamily F, member 16,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 4, subfamily F, member 29; olfactory receptor, family 4, subfamily F, member 3; olfactory receptor, family 4, subfamily F, member 16,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 4, subfamily F, member 29; olfactory receptor, family 4, subfamily F, member 3; olfactory receptor, family 4, subfamily F, member 16,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 4, subfamily F, member 29; olfactory receptor, family 4, subfamily F, member 3; olfactory receptor, family 4, subfamily F, member 16,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 4, subfamily F, member 29; olfactory receptor, family 4, subfamily F, member 3; olfactory receptor, family 4, subfamily F, member 16,UP_SEQ_FEATURE[850035770$chain:Olfactory receptor 4F3/4F16/4F29, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 6, subfamily C, member 74,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 6, subfamily C, member 74,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 6, subfamily C, member 74,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 6, subfamily C, member 74,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 6, subfamily C, member 74,UP_SEQ_FEATURE[850035918$chain:Olfactory receptor 6C74, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ovo-like 1(Drosophila),INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like]
ovo-like 1(Drosophila),PIR_SUPERFAMILY[630029859$PIRSF038264:transcription factor, Ovol1/Ovol2 types, 630031034$PIRSF500888:transcription factor Ovol1]
ovo-like 1(Drosophila),SMART[760000323$SM00355:ZnF_C2H2]
ovo-like 1(Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
ovo-like 1(Drosophila),UP_SEQ_FEATURE[850054800$chain:Putative transcription factor Ovo-like 1, 850117294$sequence conflict, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4]
ovochymase 1,INTERPRO[450000750$IPR000859:CUB, 450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
ovochymase 1,SMART[760000013$SM00020:Tryp_SPc, 760000034$SM00042:CUB]
ovochymase 1,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000937$metal-binding, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001383$Serine protease, 790001405$signal, 790001652$zymogen]
ovochymase 1,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850036449$chain:Ovochymase-1, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103444$domain:CUB 2, 850103453$domain:CUB 3, 850104965$domain:Peptidase S1 1, 850104966$domain:Peptidase S1 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105909$metal ion-binding site:Calcium, 850109636$propeptide:Activation peptide, 850117295$sequence variant, 850117814$signal peptide]
parvin, gamma,INTERPRO[450001520$IPR001715:Calponin-like actin-binding]
parvin, gamma,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion]
parvin, gamma,SMART[760000025$SM00033:CH]
parvin, gamma,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000256$cell adhesion, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000919$membrane, 790001304$repeat]
parvin, gamma,UP_SEQ_FEATURE[850020571$chain:Gamma-parvin, 850103318$domain:CH 1, 850103319$domain:CH 2, 850118574$splice variant]
peptidase inhibitor 3, skin-derived,INTERPRO[450001858$IPR002098:Seminal vesicle protein I, 450007512$IPR008197:Whey acidic protein, 4-disulphide core, 450014297$IPR015874:4-disulphide core, 450016370$IPR018069:Whey acidic protein, 4-disulphide core, conserved site, 450017778$IPR019541:Trappin protein transglutaminase binding domain]
peptidase inhibitor 3, skin-derived,PIR_SUPERFAMILY[630001792$PIRSF001624:four-disulfide core domain protein, WAP-type]
peptidase inhibitor 3, skin-derived,SMART[760000190$SM00217:WAP]
peptidase inhibitor 3, skin-derived,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790001212$polymorphism, 790001253$protease inhibitor, 790001304$repeat, 790001363$Secreted, 790001385$Serine protease inhibitor, 790001387$serine proteinase inhibitor, 790001405$signal]
peptidase inhibitor 3, skin-derived,UP_SEQ_FEATURE[850017028$chain:Elafin, 850102883$disulfide bond, 850105688$domain:WAP, 850105852$helix, 850110090$region of interest:2 X tandem repeats of SVP-1 like motif, 850117057$repeat:SVP-1 clotting 1, 850117058$repeat:SVP-1 clotting 2, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
peptidoglycan recognition protein 1,BIOCARTA[30000300$h_tollPathway:Toll-Like Receptor Pathway]
peptidoglycan recognition protein 1,INTERPRO[450002222$IPR002502:N-acetylmuramoyl-L-alanine amidase, family 2, 450006038$IPR006619:Peptidoglycan recognition protein, metazoa/bacteria, 450013950$IPR015510:Peptidoglycan recognition protein, 450015655$IPR017331:Peptidoglycan recognition protein, PGRP-S]
peptidoglycan recognition protein 1,PIR_SUPERFAMILY[630029514$PIRSF037945:peptidoglycan recognition protein, PGRP-S type, 630029515$PIRSF037945:PGRPs]
peptidoglycan recognition protein 1,SMART[760000559$SM00644:Ami_2, 760000608$SM00701:PGRP]
peptidoglycan recognition protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000092$antibiotic, 790000100$Antimicrobial, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000763$immune response, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
peptidoglycan recognition protein 1,UP_SEQ_FEATURE[850037596$chain:Peptidoglycan recognition protein 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
peroxisomal biogenesis factor 11 gamma,INTERPRO[450007987$IPR008733:Peroxisomal biogenesis factor 11]
peroxisomal biogenesis factor 11 gamma,PIR_SUPERFAMILY[630002578$PIRSF002461:peroxisomal membrane protein 11]
peroxisomal biogenesis factor 11 gamma,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001128$peroxisome, 790001212$polymorphism, 790001555$transmembrane]
peroxisomal biogenesis factor 11 gamma,UP_SEQ_FEATURE[850037949$chain:Peroxisomal membrane protein 11C, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila),INTERPRO[450001836$IPR002073:3'5'-cyclic nucleotide phosphodiesterase, 450003167$IPR003607:Metal-dependent phosphohydrolase, HD region]
phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila),PIR_SUPERFAMILY[630001110$PIRSF000960:3',5'-cyclic-nucleotide phosphodiesterase 1B, calmodulin-dependent]
phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila),SMART[760000416$SM00471:HDc]
phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000220$camp, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism]
phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000259$binding site:cAMP, 850009253$chain:cAMP-specific 3',5'-cyclic phosphodiesterase 4C, 850105852$helix, 850105987$metal ion-binding site:Divalent metal cation 1, 850105990$metal ion-binding site:Divalent metal cation 2, 850106258$modified residue, 850106269$nucleotide phosphate-binding region:cAMP, 850117294$sequence conflict, 850117295$sequence variant, 850117840$site:Binds AMP, but not cAMP, 850118574$splice variant, 850118575$strand, 850118624$turn]
polycomb group ring finger 5,COG_ONTOLOGY[90000073$General function prediction only]
polycomb group ring finger 5,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
polycomb group ring finger 5,SMART[760000158$SM00184:RING]
polycomb group ring finger 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
polycomb group ring finger 5,UP_SEQ_FEATURE[850039824$chain:Polycomb group RING finger protein 5, 850118574$splice variant, 850118911$zinc finger region:RING-type]
polyglutamine binding protein 1,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP]
polyglutamine binding protein 1,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
polyglutamine binding protein 1,OMIM_DISEASE[520002176$Golabi-Ito-Hall syndrome, 520004246$Renpenning syndrome]
polyglutamine binding protein 1,SMART[760000401$SM00456:WW]
polyglutamine binding protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000930$mental retardation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
polyglutamine binding protein 1,UP_SEQ_FEATURE[850039875$chain:Polyglutamine-binding protein 1, 850102404$compositionally biased region:Arg-rich, 850105731$domain:WW, 850106258$modified residue, 850106259$mutagenesis site, 850110209$region of interest:3 X 2 AA tandem repeats of [DE]-R, 850110502$region of interest:5 X 7 AA approximate tandem repeats of D- R-[SG]-H-D-K-S, 850110646$region of interest:7 X 2 AA tandem repeats of [DE]-R, 850115075$repeat:1-1, 850115091$repeat:1-2, 850115103$repeat:1-3, 850115113$repeat:1-4, 850115116$repeat:1-5, 850115274$repeat:2-1, 850115291$repeat:2-2, 850115306$repeat:2-3, 850115418$repeat:3-1, 850115430$repeat:3-2, 850115435$repeat:3-3, 850115436$repeat:3-4, 850115438$repeat:3-5, 850115439$repeat:3-6, 850115440$repeat:3-7, 850117294$sequence conflict, 850117295$sequence variant, 850118448$site:Not acetylated, 850118574$splice variant]
post-GPI attachment to proteins 2,INTERPRO[450017640$IPR019402:Frag1/DRAM/Sfk1]
post-GPI attachment to proteins 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000629$gpi-anchor biosynthesis, 790000919$membrane, 790001555$transmembrane]
post-GPI attachment to proteins 2,UP_SEQ_FEATURE[850040025$chain:Post-GPI attachment to proteins factor 2, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,COG_ONTOLOGY[90000073$General function prediction only]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450001859$IPR002099:DNA mismatch repair protein, 450003155$IPR003594:ATP-binding region, ATPase-like, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450013876$IPR015434:Post Meiotic Segregation 2, 450014303$IPR015880:Zinc finger, C2H2-like]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,PIR_SUPERFAMILY[630005483$PIRSF005559:zinc finger protein ZFP-36]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2, 760000339$SM00387:HATPase_c]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000459$dna repair, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,UP_SEQ_FEATURE[850040030$chain:Postmeiotic segregation increased 2-like protein 3, 850101440$chain:Zinc finger protein 12, 850104552$domain:KRAB, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8]
protein arginine methyltransferase 1,BIOCARTA[30000042$h_btg2Pathway:BTG family proteins and cell cycle regulation, 30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
protein arginine methyltransferase 1,PIR_SUPERFAMILY[630028639$PIRSF037127:type 1 arginine N-methyltransferase, 630030629$PIRSF500400:arginine N-methyltransferase, PRTM1/HMT1 types]
protein arginine methyltransferase 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001348$s-adenosyl-l-methionine, 790001547$transferase]
protein arginine methyltransferase 1,UP_SEQ_FEATURE[850000532$binding site:S-adenosyl-L-methionine, 850000543$binding site:S-adenosyl-L-methionine; via carbonyl oxygen, 850045066$chain:Protein arginine N-methyltransferase 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
protein kinase, cAMP-dependent, regulatory, type II, alpha,BIOCARTA[30000011$h_akap13Pathway:Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation, 30000012$h_akap95Pathway:AKAP95 role in mitosis and chromosome dynamics, 30000013$h_akapCentrosomePathway:Protein Kinase A at the Centrosome]
protein kinase, cAMP-dependent, regulatory, type II, alpha,INTERPRO[450000508$IPR000595:Cyclic nucleotide-binding, 450002111$IPR002373:cAMP/cGMP-dependent protein kinase, 450002741$IPR003117:cAMP-dependent protein kinase, regulatory subunit, type I/II alpha/beta, 450010958$IPR012198:cAMP-dependent protein kinase regulatory subunit, 450013163$IPR014710:RmlC-like jelly roll fold, 450016762$IPR018488:Cyclic nucleotide-binding, conserved site]
protein kinase, cAMP-dependent, regulatory, type II, alpha,KEGG_PATHWAY[470038843$hsa04210:Apoptosis, 470038882$hsa04910:Insulin signaling pathway]
protein kinase, cAMP-dependent, regulatory, type II, alpha,PIR_SUPERFAMILY[630000651$PIRSF000548:cAMP-dependent protein kinase, regulatory subunit, 630000652$PIRSF000548:PK_regulatory]
protein kinase, cAMP-dependent, regulatory, type II, alpha,SMART[760000088$SM00100:cNMP, 760000346$SM00394:RIIa]
protein kinase, cAMP-dependent, regulatory, type II, alpha,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000149$autophosphorylation, 790000220$camp, 790000221$cAMP binding, 790000223$camp-binding, 790000356$complete proteome, 790000473$duplication, 790000686$heterotetramer, 790000701$homodimer, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001304$repeat]
protein kinase, cAMP-dependent, regulatory, type II, alpha,UP_SEQ_FEATURE[850000260$binding site:cAMP 1, 850000261$binding site:cAMP 2, 850009243$chain:cAMP-dependent protein kinase type II- alpha regulatory subunit, 850105852$helix, 850106258$modified residue, 850106270$nucleotide phosphate-binding region:cAMP 1, 850106272$nucleotide phosphate-binding region:cAMP 2, 850111441$region of interest:Dimerization and phosphorylation]
protein tyrosine phosphatase, non-receptor type 20B; protein tyrosine phosphatase, non-receptor type 20A,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, non-receptor type 20B; protein tyrosine phosphatase, non-receptor type 20A,SMART[760000168$SM00194:PTPc]
protein tyrosine phosphatase, non-receptor type 20B; protein tyrosine phosphatase, non-receptor type 20A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000960$microtubule, 790001065$nucleus, 790001162$phosphoprotein, 790001261$protein phosphatase, 790001301$receptor]
protein tyrosine phosphatase, non-receptor type 20B; protein tyrosine phosphatase, non-receptor type 20A,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850067653$chain:Tyrosine-protein phosphatase non-receptor type 20, 850105593$domain:Tyrosine-protein phosphatase, 850106258$modified residue, 850118574$splice variant]
protein tyrosine phosphatase, receptor type, J,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, receptor type, J,KEGG_PATHWAY[470038856$hsa04520:Adherens junction]
protein tyrosine phosphatase, receptor type, J,OMIM_DISEASE[520001084$Colon cancer, somatic]
protein tyrosine phosphatase, receptor type, J,PIR_SUPERFAMILY[630002138$PIRSF001999:protein-tyrosine-phosphatase, receptor type J]
protein tyrosine phosphatase, receptor type, J,SMART[760000051$SM00060:FN3, 760000168$SM00194:PTPc]
protein tyrosine phosphatase, receptor type, J,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, receptor type, J,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850056943$chain:Receptor-type tyrosine-protein phosphatase eta, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850103860$domain:Fibronectin type-III 3, 850103871$domain:Fibronectin type-III 4, 850103882$domain:Fibronectin type-III 5, 850103893$domain:Fibronectin type-III 6, 850103905$domain:Fibronectin type-III 7, 850103917$domain:Fibronectin type-III 8, 850103930$domain:Fibronectin type-III 9, 850105593$domain:Tyrosine-protein phosphatase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
purinergic receptor P2X, ligand-gated ion channel, 7,INTERPRO[450001272$IPR001429:P2X purinoreceptor, 450002677$IPR003050:P2X7 purinoceptor]
purinergic receptor P2X, ligand-gated ion channel, 7,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038833$hsa04080:Neuroactive ligand-receptor interaction]
purinergic receptor P2X, ligand-gated ion channel, 7,OMIM_DISEASE[520002854$Leukemia, chronic lymphatic, susceptibility to]
purinergic receptor P2X, ligand-gated ion channel, 7,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001555$transmembrane, 790001558$transport]
purinergic receptor P2X, ligand-gated ion channel, 7,UP_SEQ_FEATURE[850036622$chain:P2X purinoceptor 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ras responsive element binding protein 1,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
ras responsive element binding protein 1,SMART[760000323$SM00355:ZnF_C2H2]
ras responsive element binding protein 1,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
ras responsive element binding protein 1,UP_SEQ_FEATURE[850056861$chain:Ras-responsive element-binding protein 1, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
regulator of G-protein signaling 4,INTERPRO[450000294$IPR000342:Regulator of G protein signalling]
regulator of G-protein signaling 4,OMIM_DISEASE[520004400$Schizophrenia, susceptibility to]
regulator of G-protein signaling 4,PIR_SUPERFAMILY[630005694$PIRSF005770:regulator of G protein signaling, RGS4 type]
regulator of G-protein signaling 4,SMART[760000285$SM00315:RGS]
regulator of G-protein signaling 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000881$lipoprotein, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism, 790001408$Signal transduction inhibitor]
regulator of G-protein signaling 4,UP_SEQ_FEATURE[850057033$chain:Regulator of G-protein signaling 4, 850105178$domain:RGS, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850117295$sequence variant]
ribosomal RNA processing 12 homolog (S. cerevisiae),INTERPRO[450011654$IPR012978:Region of unknown function, NUC173]
ribosomal RNA processing 12 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
ribosomal RNA processing 12 homolog (S. cerevisiae),UP_SEQ_FEATURE[850058650$chain:RRP12-like protein, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
ribosomal protein L37a,INTERPRO[450002372$IPR002674:Ribosomal protein L37ae, 450010228$IPR011331:Ribosomal protein L37ae/L37e, core]
ribosomal protein L37a,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L37a,PIR_SUPERFAMILY[630002370$PIRSF002238:ribosomal protein, L37Aa/L37Ae/L43e types]
ribosomal protein L37a,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
ribosomal protein L37a,UP_SEQ_FEATURE[850002774$chain:60S ribosomal protein L37a, 850118762$zinc finger region:C4-type]
ribosomal protein L7a pseudogene 70; ribosomal protein L7a; ribosomal protein L7a pseudogene 30; ribosomal protein L7a pseudogene 66; ribosomal protein L7a pseudogene 27; ribosomal protein L7a pseudogene 11; ribosomal protein L7a pseudogene 62,INTERPRO[450001701$IPR001921:Ribosomal protein L7A, 450003555$IPR004037:Ribosomal protein L7Ae conserved site, 450003556$IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45, 450016764$IPR018492:Ribosomal protein L7A/RS6 family]
ribosomal protein L7a pseudogene 70; ribosomal protein L7a; ribosomal protein L7a pseudogene 30; ribosomal protein L7a pseudogene 66; ribosomal protein L7a pseudogene 27; ribosomal protein L7a pseudogene 11; ribosomal protein L7a pseudogene 62,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L7a pseudogene 70; ribosomal protein L7a; ribosomal protein L7a pseudogene 30; ribosomal protein L7a pseudogene 66; ribosomal protein L7a pseudogene 27; ribosomal protein L7a pseudogene 11; ribosomal protein L7a pseudogene 62,PIR_SUPERFAMILY[630002297$PIRSF002165:ribosomal protein, L7Ab/L7Aa/L7Ae/L8e types/H/ACA ribonucleoprotein complex, NHP2 subunit]
ribosomal protein L7a pseudogene 70; ribosomal protein L7a; ribosomal protein L7a pseudogene 30; ribosomal protein L7a pseudogene 66; ribosomal protein L7a pseudogene 27; ribosomal protein L7a pseudogene 11; ribosomal protein L7a pseudogene 62,SP_PIR_KEYWORDS[790000012$acetylation, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001212$polymorphism, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
ribosomal protein L7a pseudogene 70; ribosomal protein L7a; ribosomal protein L7a pseudogene 30; ribosomal protein L7a pseudogene 66; ribosomal protein L7a pseudogene 27; ribosomal protein L7a pseudogene 11; ribosomal protein L7a pseudogene 62,UP_SEQ_FEATURE[850002824$chain:60S ribosomal protein L7a, 850106258$modified residue, 850117295$sequence variant]
ribosome binding protein 1 homolog 180kDa (dog),INTERPRO[450007145$IPR007794:Ribosome receptor lysine or proline rich]
ribosome binding protein 1 homolog 180kDa (dog),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001554$translocation, 790001555$transmembrane, 790001558$transport]
ribosome binding protein 1 homolog 180kDa (dog),UP_SEQ_FEATURE[850058030$chain:Ribosome-binding protein 1, 850106258$modified residue, 850110439$region of interest:41 X 10 AA approximate tandem repeats of [TN]-Q-[GSA]-[KRQT]-K-[ATGSV]-[ED]- [GTAS]-[ATIS]-[PQTAS], 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115380$repeat:24, 850115392$repeat:25, 850115404$repeat:26, 850115408$repeat:27, 850115410$repeat:28, 850115412$repeat:29, 850115417$repeat:3, 850115444$repeat:30, 850115445$repeat:31, 850115447$repeat:32, 850115449$repeat:33, 850115452$repeat:34; approximate, 850115453$repeat:35, 850115456$repeat:36; approximate, 850115457$repeat:37, 850115459$repeat:38, 850115462$repeat:39; approximate, 850115467$repeat:4, 850115483$repeat:40, 850115485$repeat:41, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
secreted LY6/PLAUR domain containing 1,INTERPRO[450001358$IPR001526:CD59 antigen, 450014439$IPR016054:Ly-6 antigen / uPA receptor -like, 450016648$IPR018363:CD59 antigen, conserved site]
secreted LY6/PLAUR domain containing 1,OMIM_DISEASE[520003134$Meleda disease]
secreted LY6/PLAUR domain containing 1,SMART[760000116$SM00134:LU]
secreted LY6/PLAUR domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790001101$palmoplantar keratoderma, 790001363$Secreted, 790001405$signal]
secreted LY6/PLAUR domain containing 1,UP_SEQ_FEATURE[850059125$chain:Secreted Ly-6/uPAR-related protein 1, 850102883$disulfide bond, 850105609$domain:UPAR/Ly6, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
secretoglobin, family 2A, member 1,INTERPRO[450003185$IPR003627:Mammaglobin/Prostatein, 450005477$IPR006038:Uteroglobin-like superfamily, 450014487$IPR016126:Secretoglobin]
secretoglobin, family 2A, member 1,PIR_SUPERFAMILY[630002653$PIRSF002537:uteroglobin]
secretoglobin, family 2A, member 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790001405$signal]
secretoglobin, family 2A, member 1,UP_SEQ_FEATURE[850030349$chain:Mammaglobin-B, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide]
secretogranin V (7B2 protein),INTERPRO[450007291$IPR007945:Neuroendocrine 7B2 precursor]
secretogranin V (7B2 protein),PIR_SUPERFAMILY[630001950$PIRSF001813:neuroendocrine protein 7B2]
secretogranin V (7B2 protein),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000090$anterior pituitary, 790000288$Chaperone, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790001021$neuropeptide, 790001162$phosphoprotein, 790001363$Secreted, 790001405$signal, 790001461$sulfation, 790001558$transport]
secretogranin V (7B2 protein),UP_SEQ_FEATURE[850033305$chain:N-terminal peptide, 850033963$chain:Neuroendocrine protein 7B2, 850102883$disulfide bond, 850106258$modified residue, 850106960$peptide:C-terminal peptide, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
seizure related 6 homolog (mouse)-like 2,INTERPRO[450000373$IPR000436:Sushi/SCR/CCP, 450000750$IPR000859:CUB, 450014444$IPR016060:Complement control module]
seizure related 6 homolog (mouse)-like 2,SMART[760000024$SM00032:CCP, 760000034$SM00042:CUB]
seizure related 6 homolog (mouse)-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001471$sushi, 790001555$transmembrane]
seizure related 6 homolog (mouse)-like 2,UP_SEQ_FEATURE[850059233$chain:Seizure 6-like protein 2, 850102586$compositionally biased region:Pro-rich, 850102605$compositionally biased region:Thr-rich, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103444$domain:CUB 2, 850103453$domain:CUB 3, 850105416$domain:Sushi 1, 850105429$domain:Sushi 2, 850105440$domain:Sushi 3, 850105446$domain:Sushi 4, 850105447$domain:Sushi 5, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
serine/threonine kinase 36, fused homolog (Drosophila),INTERPRO[450000307$IPR000357:HEAT, 450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450010814$IPR011989:Armadillo-like helical, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
serine/threonine kinase 36, fused homolog (Drosophila),KEGG_PATHWAY[470038849$hsa04340:Hedgehog signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038907$hsa05217:Basal cell carcinoma]
serine/threonine kinase 36, fused homolog (Drosophila),SMART[760000193$SM00220:S_TKc]
serine/threonine kinase 36, fused homolog (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
serine/threonine kinase 36, fused homolog (Drosophila),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059745$chain:Serine/threonine-protein kinase 36, 850105086$domain:Protein kinase, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
shisa homolog 5 (Xenopus laevis),KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
shisa homolog 5 (Xenopus laevis),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
shisa homolog 5 (Xenopus laevis),UP_SEQ_FEATURE[850047670$chain:Protein shisa-5, 850102582$compositionally biased region:Poly-Thr, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 22 (organic anion/urate transporter), member 11,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
solute carrier family 22 (organic anion/urate transporter), member 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
solute carrier family 22 (organic anion/urate transporter), member 11,UP_SEQ_FEATURE[850061387$chain:Solute carrier family 22 member 11, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,BIOCARTA[30000178$h_malatexPathway:Shuttle for transfer of acetyl groups from mitochondria to the cytosol]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450001872$IPR002113:Adenine nucleotide translocator 1, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001304$repeat, 790001550$transit peptide, 790001555$transmembrane, 790001558$transport]
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1,UP_SEQ_FEATURE[850066548$chain:Tricarboxylate transport protein, mitochondrial, 850106258$modified residue, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117294$sequence conflict, 850118617$transit peptide:Mitochondrion, 850118623$transmembrane region]
spermatogenesis associated 20,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
spermatogenesis associated 20,INTERPRO[450004353$IPR004879:Protein of unknown function DUF255, 450011036$IPR012335:Thioredoxin fold]
spermatogenesis associated 20,PIR_SUPERFAMILY[630006343$PIRSF006402:uncharacterized protein with thioredoxin domain]
spermatogenesis associated 20,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001212$polymorphism, 790001405$signal, 790001426$spermatogenesis]
spermatogenesis associated 20,UP_SEQ_FEATURE[850061885$chain:Spermatogenesis-associated protein 20, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
spondin 2, extracellular matrix protein,INTERPRO[450000771$IPR000884:Thrombospondin, type 1 repeat, 450008568$IPR009465:Spondin, N-terminal]
spondin 2, extracellular matrix protein,OMIM_DISEASE[520004444$Sequence Variants in the RNF212 Gene Associate with Genomewide Recombination Rate]
spondin 2, extracellular matrix protein,SMART[760000182$SM00209:TSP1]
spondin 2, extracellular matrix protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000763$immune response, 790000937$metal-binding, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
spondin 2, extracellular matrix protein,UP_SEQ_FEATURE[850062093$chain:Spondin-2, 850102883$disulfide bond, 850105381$domain:Spondin, 850105554$domain:TSP type-1, 850105756$glycosylation site:C-linked (Man), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850105946$metal ion-binding site:Calcium; via carbonyl oxygen, 850105986$metal ion-binding site:Divalent metal cation, 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide, 850118272$site:Important for metal ion-dependent interaction with integrin, 850118575$strand, 850118624$turn]
synaptophysin,INTERPRO[450001132$IPR001285:Synaptophysin/synaptoporin, 450007548$IPR008253:Marvel, 450013899$IPR015457:Synaptophysin]
synaptophysin,PIR_SUPERFAMILY[630005450$PIRSF005523:synaptophysin]
synaptophysin,SP_PIR_KEYWORDS[790000211$calcium, 790000263$cell junction, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000616$glycoprotein, 790000919$membrane, 790000925$membrane trafficking, 790001162$phosphoprotein, 790001304$repeat, 790001475$synapse, 790001477$Synaptosome, 790001484$tandem repeat, 790001555$transmembrane, 790001556$transmembrane protein, 790001592$ubl conjugation]
synaptophysin,UP_SEQ_FEATURE[850063188$chain:Synaptophysin, 850104755$domain:MARVEL, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850114212$region of interest:Repeats, Gly-rich, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118606$topological domain:Vesicular, 850118623$transmembrane region]
taste receptor, type 2, member 10,INTERPRO[450007304$IPR007960:Mammalian taste receptor]
taste receptor, type 2, member 10,KEGG_PATHWAY[470038880$hsa04742:Taste transduction]
taste receptor, type 2, member 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001487$Taste, 790001546$transducer, 790001555$transmembrane]
taste receptor, type 2, member 10,UP_SEQ_FEATURE[850063546$chain:Taste receptor type 2 member 10, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
taste receptor, type 2, member 14,INTERPRO[450007304$IPR007960:Mammalian taste receptor]
taste receptor, type 2, member 14,KEGG_PATHWAY[470038880$hsa04742:Taste transduction]
taste receptor, type 2, member 14,SP_PIR_KEYWORDS[790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001487$Taste, 790001546$transducer, 790001555$transmembrane]
taste receptor, type 2, member 14,UP_SEQ_FEATURE[850063569$chain:Taste receptor type 2 member 14, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
tektin 2 (testicular),INTERPRO[450000372$IPR000435:Tektin]
tektin 2 (testicular),PIR_SUPERFAMILY[630005920$PIRSF005981:tektin A1]
tektin 2 (testicular),SP_PIR_KEYWORDS[790000267$cell projection, 790000321$cilium, 790000322$cilium biogenesis/degradation, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000557$flagellum, 790000960$microtubule, 790001212$polymorphism]
tektin 2 (testicular),UP_SEQ_FEATURE[850063742$chain:Tektin-2, 850117294$sequence conflict, 850117295$sequence variant]
tet oncogene family member 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000437$dioxygenase, 790000802$iron, 790000937$metal-binding, 790001092$oxidoreductase, 790001212$polymorphism]
tet oncogene family member 3,UP_SEQ_FEATURE[850000176$binding site:2-oxoglutarate, 850042782$chain:Probable methylcytosine dioxygenase TET3, 850106100$metal ion-binding site:Iron; catalytic, 850117295$sequence variant, 850118574$splice variant]
tetratricopeptide repeat domain 25,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
tetratricopeptide repeat domain 25,SMART[760000020$SM00028:TPR]
tetratricopeptide repeat domain 25,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
tetratricopeptide repeat domain 25,UP_SEQ_FEATURE[850064010$chain:Tetratricopeptide repeat protein 25, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
trafficking protein particle complex 9,INTERPRO[450012530$IPR013935:Transport protein Trs120]
trafficking protein particle complex 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000434$differentiation, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790001162$phosphoprotein]
trafficking protein particle complex 9,UP_SEQ_FEATURE[850064889$chain:Trafficking protein particle complex subunit 9, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
transglutaminase 5,INTERPRO[450000965$IPR001102:Transglutaminase, N-terminal, 450002585$IPR002931:Transglutaminase-like, 450008173$IPR008957:Fibronectin, type III-like fold, 450008174$IPR008958:Transglutaminase, C-terminal, 450012396$IPR013783:Immunoglobulin-like fold, 450012414$IPR013808:Transglutaminase, conserved site]
transglutaminase 5,OMIM_DISEASE[520003946$peeling skin syndrome (PSS), 520003947$Peeling skin syndrome, acral type]
transglutaminase 5,PIR_SUPERFAMILY[630000540$PIRSF000459:protein-glutamine gamma-glutamyltransferase/erythrocyte membrane protein band 4.2, 630030611$PIRSF500382:protein-glutamine gamma-glutamyltransferase]
transglutaminase 5,SMART[760000405$SM00460:TGc]
transglutaminase 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000025$Acyltransferase, 790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000937$metal-binding, 790001212$polymorphism, 790001547$transferase]
transglutaminase 5,UP_SEQ_FEATURE[850048606$chain:Protein-glutamine gamma- glutamyltransferase 5, 850105909$metal ion-binding site:Calcium, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
transition protein 2 (during histone to protamine replacement),INTERPRO[450000579$IPR000678:Nuclear transition protein 2]
transition protein 2 (during histone to protamine replacement),OMIM_DISEASE[520003249$Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci]
transition protein 2 (during histone to protamine replacement),PIR_SUPERFAMILY[630002197$PIRSF002066:spermatid transition protein 2]
transition protein 2 (during histone to protamine replacement),SP_PIR_KEYWORDS[790000315$chromosomal protein, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001058$nucleosome core, 790001065$nucleus, 790001212$polymorphism, 790001426$spermatogenesis, 790001648$zinc]
transition protein 2 (during histone to protamine replacement),UP_SEQ_FEATURE[850035112$chain:Nuclear transition protein 2, 850117295$sequence variant]
transmembrane protein 134,INTERPRO[450007853$IPR008590:Uncharacterised protein family UPF0414]
transmembrane protein 134,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
transmembrane protein 134,UP_SEQ_FEATURE[850066040$chain:Transmembrane protein 134, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase),INTERPRO[450000534$IPR000626:Ubiquitin, 450001239$IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, 450016487$IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup]
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase),PIR_SUPERFAMILY[630013098$PIRSF016322:ubiquitin carboxyl-terminal hydrolase]
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase),SMART[760000186$SM00213:UBQ]
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000619$glycosyltransferase, 790000743$hydrolase, 790001116$pentosyltransferase, 790001162$phosphoprotein, 790001252$Protease, 790001509$thiol protease, 790001571$tRNA modification, 790001593$ubl conjugation pathway]
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase),UP_SEQ_FEATURE[850067954$chain:Ubiquitin carboxyl-terminal hydrolase 14, 850105602$domain:Ubiquitin-like, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
ubiquitin specific peptidase 5 (isopeptidase T),COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
ubiquitin specific peptidase 5 (isopeptidase T),INTERPRO[450000382$IPR000449:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, 450001239$IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, 450001425$IPR001607:Zinc finger, UBP-type, 450014352$IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote, 450014973$IPR016652:Ubiquitinyl hydrolase, 450016487$IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site]
ubiquitin specific peptidase 5 (isopeptidase T),PIR_SUPERFAMILY[630013083$PIRSF016308:ubiquitin-specific protease (ubiquitin carboxyl-terminal hydrolase), 630013084$PIRSF016308:UBP]
ubiquitin specific peptidase 5 (isopeptidase T),SMART[760000144$SM00165:UBA, 760000261$SM00290:ZnF_UBP]
ubiquitin specific peptidase 5 (isopeptidase T),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790000937$metal-binding, 790001162$phosphoprotein, 790001252$Protease, 790001304$repeat, 790001509$thiol protease, 790001512$thiolester hydrolase, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
ubiquitin specific peptidase 5 (isopeptidase T),UP_SEQ_FEATURE[850067997$chain:Ubiquitin carboxyl-terminal hydrolase 5, 850105598$domain:UBA 1, 850105599$domain:UBA 2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118945$zinc finger region:UBP-type]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),OMIM_DISEASE[520003206$Mental retardation, X-linked syndromic]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),PIR_SUPERFAMILY[630001738$PIRSF001567:ubiquitin-protein ligase E2]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),SMART[760000185$SM00212:UBCc]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000859$ligase, 790001063$nucleotide-binding, 790001593$ubl conjugation pathway]
ubiquitin-conjugating enzyme E2A (RAD6 homolog),UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850068077$chain:Ubiquitin-conjugating enzyme E2 A, 850117294$sequence conflict]
uncoupling protein 3 (mitochondrial, proton carrier),INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001798$IPR002030:Mitochondrial brown fat uncoupling protein, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
uncoupling protein 3 (mitochondrial, proton carrier),OMIM_DISEASE[520003717$Obesity, severe, and type II diabetes]
uncoupling protein 3 (mitochondrial, proton carrier),PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
uncoupling protein 3 (mitochondrial, proton carrier),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000430$diabetes mellitus, 790000446$disease mutation, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001067$obesity, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
uncoupling protein 3 (mitochondrial, proton carrier),UP_SEQ_FEATURE[850032051$chain:Mitochondrial uncoupling protein 3, 850114159$region of interest:Purine nucleotide binding, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
v-crk sarcoma virus CT10 oncogene homolog (avian),BIOCARTA[30000077$h_cxcr4Pathway:CXCR4 Signaling Pathway, 30000186$h_metPathway:Signaling of Hepatocyte Growth Factor Receptor]
v-crk sarcoma virus CT10 oncogene homolog (avian),INTERPRO[450000852$IPR000980:SH2 motif, 450001294$IPR001452:Src homology-3 domain, 450010373$IPR011511:Variant SH3]
v-crk sarcoma virus CT10 oncogene homolog (avian),KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038828$hsa04012:ErbB signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038853$hsa04510:Focal adhesion, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038877$hsa04722:Neurotrophin signaling pathway, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038882$hsa04910:Insulin signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma, 470038910$hsa05220:Chronic myeloid leukemia]
v-crk sarcoma virus CT10 oncogene homolog (avian),PIR_SUPERFAMILY[630001878$PIRSF001740:crk transforming protein]
v-crk sarcoma virus CT10 oncogene homolog (avian),SMART[760000224$SM00252:SH2, 760000295$SM00326:SH3]
v-crk sarcoma virus CT10 oncogene homolog (avian),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001304$repeat, 790001397$SH2 domain, 790001398$sh3 domain]
v-crk sarcoma virus CT10 oncogene homolog (avian),UP_SEQ_FEATURE[850003829$chain:Adapter molecule crk, 850105346$domain:SH2, 850105351$domain:SH3 1, 850105353$domain:SH3 2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
von Hippel-Lindau tumor suppressor,BIOCARTA[30000138$h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System, 30000307$h_vegfPathway:VEGF, Hypoxia, and Angiogenesis]
von Hippel-Lindau tumor suppressor,INTERPRO[450002407$IPR002714:Tumour suppressor protein, von Hippel-Lindau disease]
von Hippel-Lindau tumor suppressor,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma]
von Hippel-Lindau tumor suppressor,OMIM_DISEASE[520002240$Hemangioblastoma, cerebellar, somatic, 520003978$Pheochromocytoma, 520004042$Polycythemia, benign familial, 520004230$Renal cell carcinoma, somatic, 520005051$von Hippel-Lindau syndrome]
von Hippel-Lindau tumor suppressor,PIR_SUPERFAMILY[630014449$PIRSF017788:von Hippel-Lindau disease tumor suppressor protein]
von Hippel-Lindau tumor suppressor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000053$alternative splicing, 790000356$complete proteome, 790000361$congenital erythrocytosis, 790000407$cytoplasm, 790000446$disease mutation, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001580$tumor suppressor, 790001593$ubl conjugation pathway]
von Hippel-Lindau tumor suppressor,UP_SEQ_FEATURE[850100590$chain:Von Hippel-Lindau disease tumor suppressor, 850105852$helix, 850106259$mutagenesis site, 850110721$region of interest:8 X 5 AA tandem repeats of G-[PAVG]-E-E- [DAYSLE], 850112295$region of interest:Interaction with Elongin BC complex, 850113157$region of interest:Involved in binding to CCT complex, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
wingless-type MMTV integration site family, member 10B,INTERPRO[450005264$IPR005816:Secreted growth factor Wnt protein, 450005265$IPR005817:Wnt superfamily, 450011938$IPR013302:Wnt-10 protein, 450016453$IPR018161:Secreted growth factor Wnt protein, conserved site]
wingless-type MMTV integration site family, member 10B,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038849$hsa04340:Hedgehog signaling pathway, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038907$hsa05217:Basal cell carcinoma]
wingless-type MMTV integration site family, member 10B,PIR_SUPERFAMILY[630001927$PIRSF001784:int-1 transforming protein]
wingless-type MMTV integration site family, member 10B,SMART[760000085$SM00097:WNT1]
wingless-type MMTV integration site family, member 10B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000446$disease mutation, 790000530$extracellular matrix, 790000616$glycoprotein, 790001162$phosphoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001642$wnt signaling pathway]
wingless-type MMTV integration site family, member 10B,UP_SEQ_FEATURE[850048413$chain:Protein Wnt-10b, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
within bgcn homolog (Drosophila),INTERPRO[450013803$IPR015362:Exon junction complex, Pym]
within bgcn homolog (Drosophila),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001043$nonsense-mediated mrna decay, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding, 790001551$translation regulation]
within bgcn homolog (Drosophila),UP_SEQ_FEATURE[850036876$chain:Partner of Y14 and mago, 850106258$modified residue, 850111568$region of interest:eIF2A-like, 850114353$region of interest:Required for interaction with MAGOH and RBM8A, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
zinc finger protein 222,COG_ONTOLOGY[90000118$Transcription / Cell division and chromosome partitioning]
zinc finger protein 222,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 222,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 222,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 222,UP_SEQ_FEATURE[850101502$chain:Zinc finger protein 222, 850104552$domain:KRAB, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118659$zinc finger region:C2H2-type 10; degenerate, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118730$zinc finger region:C2H2-type 6; degenerate, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 224,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 224,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 224,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 224,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
zinc finger protein 224,UP_SEQ_FEATURE[850101504$chain:Zinc finger protein 224, 850104552$domain:KRAB, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118670$zinc finger region:C2H2-type 14; degenerate, 850118671$zinc finger region:C2H2-type 15, 850118674$zinc finger region:C2H2-type 16, 850118676$zinc finger region:C2H2-type 17, 850118679$zinc finger region:C2H2-type 18, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 3,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 3,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 3,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 3,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
zinc finger protein 3,UP_SEQ_FEATURE[850101558$chain:Zinc finger protein 3, 850104552$domain:KRAB, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8]
zinc finger protein 569,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 569,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 569,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 569,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 569,UP_SEQ_FEATURE[850101749$chain:Zinc finger protein 569, 850104552$domain:KRAB, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118674$zinc finger region:C2H2-type 16, 850118676$zinc finger region:C2H2-type 17, 850118679$zinc finger region:C2H2-type 18, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 596,COG_ONTOLOGY[90000073$General function prediction only, 90000118$Transcription / Cell division and chromosome partitioning]
zinc finger protein 596,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 596,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 596,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 596,UP_SEQ_FEATURE[850101779$chain:Zinc finger protein 596, 850104552$domain:KRAB, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 646,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 646,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 655,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 655,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 655,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 655,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 655,UP_SEQ_FEATURE[850101829$chain:Zinc finger protein 655, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
zinc finger protein 831,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 831,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 831,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 831,UP_SEQ_FEATURE[850101948$chain:Zinc finger protein 831, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2]
zymogen granule protein 16 homolog B (rat),INTERPRO[450001081$IPR001229:Mannose-binding lectin]
zymogen granule protein 16 homolog B (rat),SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000848$Lectin, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
zymogen granule protein 16 homolog B (rat),UP_SEQ_FEATURE[850102357$chain:Zymogen granule protein 16 homolog B, 850102576$compositionally biased region:Poly-Leu, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide]
